University of Rhode Island

DigitalCommons@URI
Open Access Dissertations
2013

Effects of Ciona Intestinalis Distal-Less-B Nonexpression and
Overexpression on Phenotype and Downstream Targets
Matthew David Blanchette
University of Rhode Island, mdblanche@my.uri.edu

Follow this and additional works at: https://digitalcommons.uri.edu/oa_diss

Recommended Citation
Blanchette, Matthew David, "Effects of Ciona Intestinalis Distal-Less-B Nonexpression and
Overexpression on Phenotype and Downstream Targets" (2013). Open Access Dissertations. Paper 1.
https://digitalcommons.uri.edu/oa_diss/1

This Dissertation is brought to you for free and open access by DigitalCommons@URI. It has been accepted for
inclusion in Open Access Dissertations by an authorized administrator of DigitalCommons@URI. For more
information, please contact digitalcommons@etal.uri.edu.

EFFECTS OF CIONA INTESTINALIS DISTAL-LESS-B NONEXPRESSION AND
OVEREXPRESSION ON PHENOTYPE AND DOWNSTREAM TARGETS
BY
MATTHEW DAVID BLANCHETTE

A DISSERTATION SUBMITTED IN PARTIAL FULFILLMENT OF THE
REQUIREMENTS FOR THE DEGREE OF
DOCTOR OF PHILOSOPHY
IN
BIOLOGICAL SCIENCES

UNIVERSITY OF RHODE ISLAND
2013

DOCTOR OF PHILOSOPHY DISSERTATION
OF
MATTHEW BLANCHETTE

APPROVED:
Dissertation Committee:
Major Professor

Steven Irvine
Marian Goldsmith
David Nelson
Nasser Zawia
DEAN OF THE GRADUATE SCHOOL

UNIVERSITY OF RHODE ISLAND
2013

ABSTRACT

Ciona intestinalis can serve as a useful model for developmental studies in the
chordate lineage due to its basal position in the chordate phylogeny. It shows a
simplified chordate body plan during its development, during which important genetic
pathways are conserved with vertebrates, and its developmental gene regulation can be
manipulated through the insertion of transgenic DNA by electroporation. The Distalless (Dll) genes are a family of homeobox genes in chordates that are homologous to
the single Dll gene of other metazoan animal groups and code for developmental
factors that play a role in determining multiple developmental cell fates. These include
broadly conserved roles in appendage development and sensory functions of the
central nervous system, as well as more novel roles such as differentiation of the
epidermis in chordates. In C. intestinalis, Dll-B transcripts are expressed throughout
the prospective epidermis during gastrulation. To study the role of Ci-Dll-B in
development, I have produced a transgenic dominant negative form of Ci-Dll-B by
making use of the Drosophila engrailed repressor domain (EnR). I then examined its
effects on development. Embryos electroporated with this construct showed defects in
adhesion of cells in the epidermis. Whole mount in situ hybridization analysis of
known Ci-Dll-B downstream targets showed changes in gene expression only in
certain targets, suggesting a degree of redundancy in the regulation of the epidermal
development program. Phenotypic analysis and immunofluorescent staining of
epidermal markers suggest that Ci-Dll-B has a role in the regulation of cell adhesion or
differentiation, since Ci-Dll-B knock-down alters the expression pattern of collagen

and laminin. I also attempted to identify Ci-Dll-B gene targets through suppression
subtractive hybridization, but was unsuccessful. These results are consistent with
earlier reports that Dll genes could have a role inducing final differentiation in the
epidermis. This work characterizing a key gene in epidermal development may have
implications for epidermal development in other chordates, such as mammals.
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CHAPTER ONE: INTRODUCTION

The Dll gene family. The Distal-less (Dll in invertebrates, Dlx in vertebrates)
genes are a family of homeobox genes in chordates that code for developmental
transcription factors (reviewed by Bendall and Abate-Shen, 2000; Zerucha and Ekker,
2000; Panganiban and Rubenstein, 2002). The family is homologous to the Dll gene of
Drosophila and is hypothesized to have arisen through several duplications (Stock et
al., 1996; reviewed in Sumiyama et al., 2003). A duplication early in the chordate
lineage resulted in a cluster of two genes in close proximity to the Hox gene cluster
(Fig. 1.1) (reviewed in Zerucha and Ekker, 2000; Panganiban and Rubenstein, 2002;
Sumiyama et al., 2003). In lancelets, the most basal chordate group (Delsuc et al.,
2006), there is one Dll gene, (Holland et al., 1994), suggesting that this is the ancestral
condition for chordates, whereas in the vertebrate lineage further duplications have
resulted in additional bigene clusters. There are four genes in lampreys (Neidert et al.,
2001), six in elasmobranchs (Stock, 2005) and tetrapods (reviewed in Panganiban and
Rubenstein, 2002), and eight in teleost fishes (Fig 1.2) (Amores, et al., 1998).
The Dll genes code for transcription factors that play a role in determining
developmental cell fates. Dll proteins have a role in diverse lineages of metazoan
animals for programming outgrowths from the body wall (Cohen and Jurgens, 1989;
Panganiban et al., 1997; Robledo et al., 2002). In Drosophila the Distal-less gene is
expressed in the distal regions of head and thorax appendages during development; in
Dll mutants these appendages do not develop distal regions normally (Cohen and
Jurgens, 1989), which is the origin of the gene’s name. It also has an ancestral role in
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the central nervous system. This role might pre-date its role in limb development as
Dll homologs have been identified in basal metazoans without limbs, such as
nematodes (Panganiban et al., 1997). Nervous system expression of Dll homologs is
often associated with putative sensory organs, particularly olfactory and auditory
(Solomon and Fritz, 2002; de Melo et al., 2003; Long et al., 2003; Perera et al., 2004;
Brill et al., 2008; Winchell et al., 2010). Since the morphology of limb structures
showing Dll homolog expression among different animal lineages is not homologous,
and since sensory organs are frequently found on limbs, it has been speculated that this
sensory role for Dll is what led to its frequent cooption for the development of limbs
(Mittmann and Scholtz, 2001; Winchell et al., 2010). As Dll genes have been
duplicated in the chordate lineage, they have taken on new roles in chordate
development, including partitioning the ancestral role of patterning the central nervous
system with different genes to pattern separate regions (Akimenko et al., 1994;
Zerucha et al., 2000; Ghanem et al., 2003), expression in the craniofacial skeleton and
palate (Levi et al., 2006), and determining fates along the proximo-distal axis of novel
chordate facial structures arising from the pharyngeal arches (Depew et al., 2002; Park
et al., 2004; Sumiyama and Ruddle, 2003). Interestingly, new roles for Dll are not
unique to the chordate lineage. For example, in lepidopterans Dll helps pattern
localized regions in the color scales of the wings, a structure that is unique to this
lineage, where it is expressed in eyespot foci (Carroll et al., 1994; Beldade et al., 2002;
Reed and Serfas, 2004).
In chordates, members of the Dll gene family are also believed to play a role in
patterning ectodermal development, particularly in the epidermis (Imai et al., 2006;
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Irvine et al., 2007). Broad expression of a member of the Dll family has been observed
in several chordates, in the developing animal hemisphere, which is the side of the
embryo where cell division is more rapid and fated to give rise to the ectoderm. These
genes include the sole homolog in lancelets (Holland et al., 1996). In zebrafish, dlx3b
(Akimenko et al., 1994; Quint et al., 2000) and dlx4b (Ellies et al., 1997) are
expressed in the rostral ectoderm located at the anterior of the developing nervous
system. Dlx3, Dlx5, and Dlx6 are also expressed in the rostral ectoderm of murine
embryos (Quint et al., 2000). In Xenopus, Dlx3 is expressed in putative epidermis and
Dlx5 and Dlx6 are expressed in a domain at the border between ectodermal cells fated
to become epidermis and those fated to become neural cells (Dirksen et al., 1994; Luo
et al., 2001; Woda et al., 2003).
In summary, Dll genes are transcription factors with conserved roles in
appendages, sensory organs, the central nervous system, and lineage specific roles. In
the chordate lineage, where gene duplications have produced a Dlx gene family, these
last include regulation of the developing epidermis. Homologs from this gene family
display an ectodermal expression pattern consistent with this role in multiple chordate
lineages, including teleost fishes, amphibians, and mammals. Intriguingly, the Dll
homolog Ci-Dll-B has also been identified as a key regulator of epidermal
development in the ascidian Ciona intestinalis (Imai et al., 2006).
The model species Ciona intestinalis. Urochordates are the closest sister
group to vertebrates (Delsuc et al., 2006) and are located basally within the chordate
lineage (Fig. 1.2). As a basal invertebrate chordate group, urochordates can provide
both insight into the early evolution of vertebrates and a simpler chordate model than
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the more complex vertebrates. The subphylum Urochordata includes the ascidians, for
which C. intestinalis is a commonly employed model species. The similarity of
ascidian larvae to a simple vertebrate form has long been recognized (Fig. 1.3A)
(Foster, 1869) and has led to the idea that the ascidian larva represents a prototypical
chordate body plan (Garstang, 1928). Upon hatching, free-swimming tadpole larvae
display a body plan comparable to the phylotypic development stage of vertebrates
(Fig. 1.3A) including chordate-defining features such as a dorsal neural tube and a
notochord; however, after less than one day the larvae attach to a substrate using
rostral palps and begin a radical metamorphosis to a sessile form (Fig. 1.3B). In recent
years, molecular studies have revealed conservation of genetic pathways in
developmental patterning between ascidians and vertebrates (reviewed in Lemaire et
al., 2008). Even if the ascidian larva is not entirely representative of ancestral
chordates, conserved genetic pathways can provide insight into what sort of
morphological features must have been present in common ancestors and the
derivation of modern vertebrate traits (reviewed in Hall, 2003; Shubin et al., 2009).
The C. intestinalis larva has many advantages as a model of early chordate
development. It is relatively small, consisting of about 2500 cells. The early
blastomeres are large and their later fates well documented (Fig 1.4) (Conklin, 1905).
Development is rapid, proceeding from fertilization to the tadpole larva in about 18 hr
at 18o C, though varying the incubation temperature by several degrees allows for
somewhat faster or slower development (Hotta et al., 2007). Transgenic DNA can be
transformed into fertilized eggs by electroporation (Corbo et al., 1997; Vierra and
Irvine, 2012). This is typically accomplished through suspension of dechorionated
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fertilized eggs in a solution of supercoiled plasmid DNA, followed by an electrical
pulse to drive the plasmid DNA into the embryos. Transgenes are usually not
incorporated into the embryo’s genomic DNA, though this has been observed with
some techniques (Matsuoka et al., 2005), but instead produces extra-chromosomal
arrays. Expression is transient and frequently mosaic depending on which early
blastomeres incorporate the plasmid. The genome of C. intestinalis is 160 million base
pairs, one of the smallest genomes for a chordate that can be easily manipulated
experimentally (Dehal et al., 2002). The small genome contains fairly few redundant
genes, implying that inducing alterations in genes is likely to have a phenotypic effect
(Sasakura et al., 2009). The C. intestinalis genome has been sequenced (Dehal et al.,
2002), as has been the genome of C. savignyi (Vinson et al., 2005), allowing for
comparison of genomic sequences with those of a closely related species for
potentially relevant conserved regions (Johnson et al., 2004).
The Dll gene family in Ciona intestinalis. In C. intestinalis, the Dlx homolog
Dll-B is one of the key regulators of gene expression in the developing epidermis,
according to an important study which examined the regulatory connections between
dozens of regulatory genes identified in C. intestinalis (Imai et al., 2006). C.
intestinalis has three Dll genes, Dll-A, Dll-B, and Dll-C (Caracciolo et al., 2000). DllA and Dll-B are arranged in a bigene cluster (Di Gregorio et al., 1995) 2.75 megabases
downstream from the portion of the C. intestinalis Hox cluster which is present on
chromosome 7 (Irvine et al, 2007). Vertebrate Dlx homologs are also typically found
in bigene clusters downstream from Hox clusters, a shared gene ordering suggesting
homology between the C. intestinalis Dll bigene cluster and those of vertebrates (Fig.
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1.1). There is no known cluster partner for Ci-Dll-C, suggesting that it was either
formed by the duplication of a single Dll gene, or alternatively that the Dll cluster was
duplicated but only one duplicated gene remained functional. It has been hypothesized
that these clusters have been maintained because of a need to share common
regulatory regions between the genes for their correct expression (Sumiyama et al.,
2002; Irvine et al., 2007). In support of this hypothesis, regulatory regions have been
observed in the intergenic regions between Dlx genes in several chordates (Zerucha et
al., 2000; Ghanem et al., 2003; Park et al., 2004; Sumiyama and Ruddle, 2003).
Expression of Ci-Dll-A is seen in the trunk ectoderm by the mid-tailbud stage
of development. Expression continues through the larval stage and is particularly
focused on the primordia of the atrial siphon (Caraciolo et al., 2000) as well as other
sensory placode-like structures (Irvine et al., 2007). Ci-Dll-C expression begins during
gastrulation and by hatching is specifically detectable in the adhesive organ.
(Caraciolo, 2000).
In C. intestinalis, Dll-B has a chordate specific ectodermal expression pattern.
Maternal transcripts are present in the egg, but localized to the posterior vegetal
hemisphere (Caraciolo et al., 2000), the side of the embryo where cell division is less
rapid. Zygotic expression starts at the 64 cell stage and can be detected in all a-line
and b-line animal hemisphere blastomeres (Fig. 1.4), with expression being
maintained in these cell lineages into early gastrulation. In later gastrulation Dll-B
expression is confined to equatorial cells in the animal hemisphere and non-neural
ectoderm. By neurulation Dll-B expression is radically down-regulated. It becomes
restricted to isolated anterior neuroectodermal cells and during the tailbud stage is
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found in cells that are potentially precursors to the palps (Irvine et al., 2007). Ci-Dll-A
and Ci-Dll-B expression is non-overlapping with sensory expression partitioned to CiDll-A and pan-ectodermal expression partitioned to Ci-Dll-B (Irvine et al., 2007). This
is unlike what has been observed in vertebrates, where there is typically overlap in the
expression of members of the same Dlx bigene cluster. Since this unique partition of
function is not seen in other chordate lineages, it suggests that the function of the Dll
homologs in Ciona diverged after the evolutionary split from vertebrates. Dll is also
restricted to anterior expression at later embryonic stages in other ascidians,
suggesting it is especially important in this region (Wada et al., 1999).
The upstream regulators of Ci-Dll-B are unknown. However, several putative
downstream regulatory targets of Ci-Dll-B have been identified, including Ci-Emx, CiFoxC, Ci-FoxHa, Ci-SOCS1/2/3, Ci-GATA-b, Ci-SoxB2 (Fig. 1.5) (Imai et al., 2006),
and ci-ADMP (Imai et al., 2012). These putative targets also have gene regulatory
roles. Like Ci-Dll-B itself, several are also transcription factors; Emx is a homeobox
transcription factor (Patarnello et al., 1997), FoxHa and FoxC are members of the
forkhead box gene family of transcription factors (reviewed in Hannenhalli and
Kaestner, 2009), GATA-b is a zinc finger-containing transcription factor (Molkentin,
2000), and SoxB2 is a transcription factor of the HMG family (Guth and Wegner,
2008). The remaining targets have roles in cell-cell signaling pathways; SOCS1/2/3
acts as an inhibitor of cytokine signaling between cells as part of the JAK/STAT
pathway (Krebs and Hilton 2000) and ADMP is a ligand of the BMP signaling family
(Imai et al., 2012). Most of these putative targets were identified by Imai et al. (2006)
by knocking down gene expression of Ci-Dll-B at the post-transcriptional level using
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Morpholinos. Morpholino molecules consist of the standard nucleic acid nitrogenous
bases and a non-biological backbone of morpholine rings in place of ribose sugars and
phosphorodiomidate in place of ionic phosphate. A ~25-mer Morpholino antisense to
the target mRNA can bind it in the same manner as a biological nucleic acid; however,
the non-biological backbone cannot be recognized by cellular proteins, leaving
translation of the mRNA sterically blocked (Summerton and Weller, 1997). Despite
the identification of these putative targets, the functional role of Ci-Dll-B expression in
the developing epidermis is still poorly understood.
Development of the epidermis. The initial patterning of the epidermis in
chordates is still not well understood, but it is thought to begin under the influence of
maternal determinants. The identities of the initial maternal determinants vary between
chordate lineages. In zebrafish and Xenopus these initial maternal determinants
promote signaling by Nodal in the vegetal hemisphere (Schier and Talbot, 2005;
Heasman, 2006) to establish endodermal and mesodermal identities. At the animal
pole, repressors of nodal signaling such as zic2 (Houston and Wylie, 2005), sox3
(Zhang et al., 2004), and ectodermin (Dupont et al., 2005) inhibit endo-mesodermal
identity and position the border of the ectoderm. In C. intestinalis on the other hand,
nodal signaling does not establish endodermal or mesodermal identity (Hudson and
Yasuo, 2006), placing initial establishment of the ectoderm under the control of a
different maternally initiated pathway. Ectodermal identity is initially established by
Ci-GATA-a (Rothbächer et al., 2007). At the third cell division, the future ectoderm in
the animal hemisphere and endo-mesoderm in the vegetal hemisphere divide from
each other and zygotic expression of β-catenin begins, repressing GATA-a in the
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vegetal hemisphere. Expression of Ci-otx is repressed by an unidentified member of
the Ets family until the beginning of neural induction. FGF signaling then activates Ciotx in the neural ectoderm while cells where it remains repressed develop into
epidermis. Later development of the epidermis during the tailbud stage appears to be
patterned by a combinatorial code of roughly ten transcription factors while dorsal and
ventral midline identities are induced by FGF signaling and BMP signaling
respectively (Pasini et al., 2006).
The initial factor responsible for activation of Ci-Dll-B remains unknown, but
sequence analysis suggests SoxB1 and intriguingly GATA-a as possibilities (Irvine,
unpublished). In Xenopus activation of Dlx3 is mediated by BMP signaling (Suzuki et
al., 1994), presumably though the activation of an unknown regulator of Dlx3 (Beanan
and Sargent, 2000). In addition to Ci-Dll-B, other genes that imply a shared regulatory
network in the epidermis between C. intestinalis and vertebrates due to similar
expression patterns include AP2 (Snape et al., 1991; Imai et al., 2004), KLF4 (Segre et
al., 1999), Ash2l (Tan et al., 2008), and Hes1 (Fuchs, 2007).
Purpose of this study. This study has further examined the nature of Ci-Dll-B
expression in the developing epidermis through production of a transgenic dominant
negative of the Ci-Dll-B gene. This was used to examine its effects upon putative
downstream target genes, and to compare its effects to those resulting from Ci-Dll-B
misexpression in non-ectodermal tissues. Two knock-down strategies were attempted.
One sought to make use of a small interfering RNA (siRNA) construct to silence
expression of Ci-Dll-B at the post-transcriptional level, while the other produced a
transgenic construct fusing the Ci-Dll-B gene transcript with the powerful repressor
9

domain of the Drosophila engrailed gene (EnR) (Jaynes and O’Farrell, 1991; Vickers
and Sharrocks, 2002). Both constructs were expressed by vectors which drive
expression in the same cells as endogenous Ci-Dll-B. Analysis of their effects upon
known candidates for downstream regulation demonstrated that the dominant negative
construct displayed the expected effects of Ci-Dll-B knock-down while the siRNA
construct did not; therefore the dominant negative construct was used for the
remainder of this study.
The effects of the dominant negative construct upon downstream targets and
the phenotype of the embryo were used to analyze its role and compare it with what is
known about epidermal Dlx expression in vertebrates. Embryos electroporated with
this construct showed defects in adhesion and differentiation of cells in the epidermis.
In the notochord, defects were present in a mosaic pattern with some cells disrupted
and others unaffected, suggesting a possible role for Ci-Dll-B in the endo-mesoderm
mediated by cell-cell signaling. However, in these embryos the more universally
disrupted phenotypes produced by Ci-Dll-B misexpressed in endo-mesodermal tissue
under the control of an endo-mesodermal promoter were absent. Ci-Dll-B knock-down
embryos did not show a reduction of expression of all known downstream targets,
suggesting a degree of redundancy in the regulation of the epidermal development
program. Failure to detect evidence of changes in cell fates as a result of altering CiDll-B expression confirms that other factors are necessary for the establishment of an
epidermal cell fate; instead they are consistent with the hypothesis that Ci-Dll-B
expression is related to final differentiation within the epidermis. Although this
analysis suggests that Ci-Dll-B may have unidentified downstream regulatory targets
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that affect cell adhesion and differentiation, attempts to identify these targets using
suppression subtractive hybridization were unsuccessful; alternative methods may
have to be applied instead.
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Figure 1.1. Genomic Location of Ci-Dll-B and a human homologous cluster. CiDll-B is found in a convergently transcribed bigene cluster with Ci-Dll-A 2.75
megabases from the posterior of the C. intestinalis Hox cluster on chromosome 7q. In
Homo sapiens, Hs-Dlx3 and Hs-Dlx4 are found in a convergently transcribed bigene
cluster 1.25 megabases from the H. sapiens Hoxb cluster on chromosome 17. The
shared synteny of this arrangement suggests that the Ci-Dll-A/Ci-Dll-B bigene cluster
is homologous to those of vertebrates.
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Figure 1.2. Phylogeny of the chordates and the chordate Dlx gene family. The
number of genes in each lineage and the presumptive number in the ancestral chordate
are indicated. Chordate subphyla are displayed above. Presumptive gene duplication
events are indicated in red.
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Figure 1.3. Wild type Ciona intestinalis. A. Late tailbud C. intestinalis displaying the
chordate phylotypical tadpole-like morphology. B. Adult C. intestinalis showing the
post-metamorphosis sessile morphology.
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Figure 1.4. Fate map of Ciona intestinalis at the 64 cell stage. Cell lines are named
using the nomenclature from Conklin (1905). Presumptive epidermis is labeled in
green and derived from the a- and b-line blastomeres found in the animal hemisphere.
Anterior is at the left in each view and in the fate map view the animal pole is at the
top and the vegetal pole at the bottom (from Lemaire et al., 2008, p. R624).
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Figure 1.5. Ciona intestinalis developmental gene regulatory network. The
network detected in the epidermis including those genes regulated by Ci-Dll-B is
shown at the bottom. Putative regulatory connections were identified through
quantitative real time PCR (qRT-PCR) analysis of Morpholino knock-downs (from
Imai et al., 2006, p. S25).
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CHAPTER TWO: TRANSGENE CONSTRUCTION AND RESULTS

Introduction
In order to analyze the effects of a Ci-Dll-B knock-down phenotype, it was
first necessary to produce transgenes capable of reducing the expression of wild type
Ci-Dll-B. Two alternate approaches were attempted based on two mechanisms used
commonly to knock down gene expression. Several additional constructs were
produced for control purposes, including an overexpression construct to rescue the
normal phenotype.
One strategy sought to make use of RNA silencing. This involved constructing
a transgene to produce a small interfering RNA (siRNA). siRNAs are short RNA
molecules 20 to 25 base pairs long that are capable of silencing the expression of
specific genes post-transcriptionally both as an endogenous regulatory mechanism
(Hamilton and Baulcombe, 1999) and when introduced synthetically (Elbashir et al.,
2001). The antisense construct produced here was complementary to an intron-exon
junction of the Ci-Dll-B pre-mRNA. This was expected to degrade the pre-mRNA
prior to translation (Smith and Davidson, 2008), preventing expression of Ci-Dll-B.
Like in most marine invertebrates, siRNA techniques in C. intestinalis remain poorly
developed (Stolfi and Christiaen, 2012) and the method used here was recently
developed and first applied in echinoderms (Smith and Davidson, 2008). Verification
of the efficacy of this construct was therefore vital and was performed using
quantitative real time PCR (qRT-PCR) to test for the expected disappearance of CiDll-B construct from embryos electroporated with this construct. Previous experiments
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knocking down expression of Ci-Dll-B using Morpholinos, another approach which
silences gene expression at the mRNA level, detected an increase in Ci-Dll-B
transcripts using qRT-PCR (Imai et al., 2006). This raised the possibility of
confounding effects in attempting to knock down expression of Ci-Dll-B in this way;
therefore, an additional strategy was also employed.
The other strategy used was to create a fusion protein combining endogenous
Ci-Dll-B with a repressor domain. The modular nature of proteins allows the creation
of dominant negative variants of a protein by the addition of a powerful repressor
domain such as that of the Drosophila engrailed gene (Jaynes and O’Farrell, 1991).
The mechanism by which such proteins typically work is to out-compete the
endogenous gene for its binding sites in its downstream targets and then repressing
instead of activating them. This strategy is better established in Ciona intestinalis
(Spagnuolo and Di Lauro, 2002; Mita and Fujiwara, 2007) and can avoid any
confounding effects from the possibility of autoregulation. However, the functional
domains of the Ci-Dll-B protein are not fully understood; therefore, the EnR domain
was fused with the entire Ci-Dll-B coding sequence. This meant that although the
transgene created was a dominant negative construct, primers specific for Ci-Dll-B
would detect increased transcript in PCR-based verification methods as a result of also
amplifying transcript produced from the dominant negative construct. To compensate
for this, primers specific for EnR were also used alongside those for Ci-Dll-B.
Experiments to determine the phenotype produced by the Ci-Dll-B dominant
negative construct made use of transgenic electroporated embryos. Multiple doses of
transgene were attempted to determine the optimum dose for observing an effect and

18

to determine if the effect was dose dependent. Several control constructs were also
electroporated alongside the dominant negative and dechorionated wild type embryos
to test for the effects of electroporation or artificial transgene function. These included
constructs with no expected phenotypic effect to produce wild type embryos that could
also control for the effects of electroporation. Additional control constructs were used
to determine that the EnR and VP16 protein domains used in experimental constructs
lacked phenotypic effects when not attached to a DNA binding domain. Finally, a
construct which should act as a constitutively active form of Ci-Dll-B, was coelectroporated with the Ci-Dll-B dominant negative construct to determine whether the
phenotype seen in the dominant negative embryos could be rescued. Rescuing this
phenotype was evidence that the effects seen with the dominant negative construct
were due specifically to perturbation of Ci-Dll-B. As these two constructs were
competing with each other, multiple dosage ratios were used to determine the
optimum dose for a rescue phenotype.
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Materials and Methods
Transgene Cloning. Except where otherwise indicated, all transgene
constructs were ligated using T4 DNA Ligase (New England Biolabs, Ipswich, MA),
and transformed into electrocompetent E. coli DH10B by a square wave pulse
delivered using a BTX ECM 830 electroporation device (Harvard Apparatus,
Holliston, MA). All primers were designed with MacVector 9.0 (MacVector Inc.,
Cary, NC) (Table 2.1).
The CiDB-1.0::EnR/DllB (DBDN) construct was made from Ci-Dll-B clone
CiGC11g14 obtained from the Ciona Gene Collection (Satou et al., 2002) (Ghost
cDNA Database, URL: http://ghost.zool.kyoto-u.ac.jp/indexr1.html). The Ci-Dll-B
cDNA sequence was amplified with forward primer DBDNintforwad with a 5’ BamHI
site and reverse primer DBDNintreverse with a 5’ SacII site (Table 2.1) and cloned
into a Bluescript plasmid containing the engrailed repressor sequence provided by A.
Di Gregorio (Weill Cornell Medical College, New York, NY) at the SacII and BamHI
restriction sites (Fig. 2.1A). The combined Ci-Dll-B/EnR sequence was amplified with
forward primer DBDNforward with a 5’ NotI site and reverse primer DBDNreverse
with a 5’ BlpI site (Table 2.1) and cloned into the CiDB-1.0 vector (Irvine et al., 2011)
at the NotI and BlpI restriction sites.
The CiDB-1.0::DllB/VP16 (DBOE) construct was made from Ci-Dll-B clone
CiGC11g14 obtained from the Ciona Gene Collection (Satou et al., 2002). The Ci-DllB cDNA sequence was amplified with forward primer DBOEintforward with a 5’
XhoI site and reverse primer DBOEintreverse with a 5’ BamHI site (Table 2.1) and
cloned into a Bluescript plasmid containing the VP16 promoter sequence provided by
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A. Di Gregorio (Weill Cornell Medical College, New York NY) at the XhoI and
BamHI restriction sites (Fig. 2.1B). The combined Ci-Dll-B/VP16 activator sequence
was amplified with forward primer DBOEforward with a 5’ NotI site and reverse
primer DBOEreverse with a 5’ BlpI site (Table 2.1) and cloned into the CiDB-1.0
vector at the NotI and BlpI restriction sites.
The CiDB-1.0::EnR (DBEn) construct was produced by amplifying the entire
DBDN construct except for the Ci-Dll-B cDNA coding sequence and religating the
amplified product using primers DBEnforward and DBEnreverse (Table 2.1). The
CiDB-1.0::VP16 (DBVP) construct was produced by amplifying the entire DBOE
construct except for the Ci-Dll-B cDNA coding sequence and religating the amplified
product using primers DBVPforward and DBVPreverse (Table 2.1). The CiDB-5.0
construct was made from amplifying a 5kb regulatory region upstream of Ci-Dll-B
from CiDB-A vector (Irvine et al., 2011) with forward primer CiDB5.0forwardA or
CiDB5.0forwardB with a 5’ AscI site and reverse primer CiDB5.0reverseA or
CiDB5.0reverseB with a 5’ NotI site (Table 2.1). The amplified products were
hybridized as described in Zeng (1998) and cloned into the lacZ reporter gene
construct TV13 (Irvine et al., 2008) at the AscI and NotI restriction sites.
The CiDB-2.5::siRNA (DBsR) construct was made using primers
DBsRforward and DBsRreverse (Table 2.1) to amplify the entire CiDB-2.5 construct
(Irvine et al., 2011) except for the lacZ coding sequence. The DBAnti+ and DBAntioligonucleotide strands (for sequences see Table 2.1) were synthesized by Life
Technologies (Carlsbad, CA) and were annealed by mixing an equimolar solution and
heating to 95oC for 5 min, then slowly cooling to room temperature. The vector and
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double-stranded DBAnti oligonucleotide were ligated and transformed using the InFusion Dry-Down PCR Cloning Kit (Clontech, Mountain View, CA) following the
manufacturer’s instructions.
The dFoxAa::lacZ (DBFl) and dFoxAa::DllB (DBME) transgenes were
constructed using a Ci-FoxAa-lacZ reporter transgene kindly provided by A. Di
Gregorio and M. Levine (University of California, Berkeley CA). An internal deletion
that eliminated expression in ectodermal lineages (Genbank NM_001078564; Di
Gregorio et al., 2001) was used to produce DBFl. The lacZ coding sequence was
removed from DBFl and the Ci-Dll-B coding sequence, amplified by PCR from Ciona
Gene Collection clone CiGC11g14 (Satou et al., 2002) (Ghost cDNA Database, URL:
http://ghost.zool.kyoto-u.ac.jp/indexr1.html) was substituted. CiDB-1.0::RFP was
constructed using a Ciona RFP construct kindly provided by R. Zeller (San Diego
State University, San Diego CA; Genbank DQ229369.1; Zeller et al., 2006). The lacZ
coding sequence was removed from CiDB-1.0 and the RFP coding sequence was
substituted.
Sequencing to confirm success of cloning was performed by the University of
Rhode Island Genomic Sequencing Center using BigDye® Terminator v3.1 chemistry
(Applied Biosystems, Foster City, CA).
Animal methods. Adult C. intestinalis sp. B (Nydam and Harrison, 2007) were
collected from floating docks in the Point Judith Marina at Snug Harbor, RI, or the
University of New Hampshire Coastal Marine Laboratory Pier at New Castle, NH, or
supplied by Marine Research and Education Products (Carlsbad, CA). Gametes were
collected by dissection and spawned in vitro (Corbo et al., 1997). Transgenes were
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delivered by electroporation as follows. Fertilized eggs were dechorionated using 0.4
mg/ml Pronase E (P5147, Sigma, St. Louis, MO) in 1% sodium thioglycolate in
filtered sea water (FSW) pH 10.1 for 3-4 min at 18°C. 150 µl of dechorionated single
cell embryos in FSW (approx. 50 embryos) were transferred to the electroporation
solution (25–100 µg supercoiled transgene DNA in a final mannitol concentration of
0.5 M) in a 0.4 cm electroporation cuvette. A square wave pulse of approximately 30
V for 100 msec was delivered using a BTX ECM 830 electroporation device (Harvard
Apparatus, Holliston, MA). The contents of the cuvette were immediately decanted
into a gelatin-coated 150 mm × 15 mm petri dish of FSW with antibiotics (approx. 15
U penicillin and 15 µg streptomycin per ml) and incubated at 13–18°C to the desired
stages. Each construct was tested in 3 or more electroporation experiments, and the
results were pooled to derive percentages of phenotypically affected embryos. For
photography, specimens were mounted in 70% glycerol/0.01% Tween-20 using an
Olympus BX51 fluorescence DIC microscope and SPOT Flex Color imaging system
(SPOT Imaging Solutions, Sterling Heights, MI).
Semi-quantitative PCR. Embryos were reared to late gastrula to neurula stage
(~6-7 hr at 18oC). RNA was extracted using Nucleospin RNA XS (Macherey-Nagel,
Dueren, Germany) according to the supplier’s recommendations and cDNA synthesis
performed using Superscript III (Life Technologies, Carlsbad, CA) according to the
supplier’s recommendations using oligo-dT primers. Ci-β-actin (Genbank AV953066)
was used as an endogenous reference gene. Initial PCR reactions were performed to
determine the optimum number of cycles. All subsequent PCR reactions were
performed a total of 32 cycles of 15 sec at 95oC, 30 sec at 55oC, and 30 sec at 68oC
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using the Advantage 2 Polymerase Mix (Clontech, Mountain View, CA) according to
the supplier’s recommendations. Primers were designed with MacVector 9.0
(MacVector Inc., Cary, NC), except for Ci-β-actin primers (Kulman et al., 2006).
After PCR amplification, equal amounts of reaction product were analyzed on 1%
agarose gels stained with ethidium bromide. The digitized signals for each gene were
obtained by a 1D Limited Edition digital imaging system (Eastman Kodak, Rochester
NY). For primers, see Table 2.2.
Quantitative real time PCR. Embryos were electroporated with 50µg of
DBsR, 100µg of DBsR, or CiDB-5.0 and reared to early tailbud stage (~9 hr at 18oC).
RNA was extracted using Nucleospin RNA XS (Macherey-Nagel, Dueren, Germany)
according to the supplier’s recommendations and cDNA synthesis performed using
Affinity Script (Stratagene, La Jolla, CA) according to the supplier’s
recommendations using oligo-dT primers. Quantitative analysis of mRNA levels was
performed using a Brilliant II SYBR Green (Stratagene, La Jolla, CA) assay in
combination with the Mx3005P QPCR System (Stratagene, La Jolla, CA) according to
the manufacturer’s protocols. Reactions were set up and run in duplicate. Ci-β-actin
and Ci-calreticulin were used as endogenous controls. Primers were designed with
MacVector 9.0 (MacVector Inc., Cary, NC), except for Ci-β-actin primers (Kulman et
al., 2006). Each sample was assigned a Ct value indicating the PCR cycle at which
detected fluorescent emission surpassed the baseline. The collected data on target gene
expression was normalized against an average of Ci-β-actin and Ci-calreticulin
expression using the program REST-MCS version 2 (Pfaffl et al., 2002). For primers,
see Table 2.3.
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Results
Construction of CiDB-2.5::siRNA (DBsR). The first strategy used to attempt
a knock-down phenotype was the production of the siRNA expression construct. This
construct was named CiDB-2.5::siRNA (DBsR) (Fig. 2.2). DBsR was designed to
silence Ci-Dll-B through expression of an siRNA to bind the splicing site of the first
intron at the junction with the second exon in the Ci-Dll-B pre-mRNA. This
mechanism has been shown to be able to knock down gene expression in the sea
urchin Strongylocentrotus purpuratus (Smith and Davidson, 2008). The mechanism
by which this repression works is only partially understood. Smith and Davidson
(2008) demonstrated that their siRNA construct caused the target pre-mRNA to be
degraded after binding as opposed to sterically blocking splicing. However, since the
pre-mRNA does not leave the nucleus before splicing, degradation cannot be due to
classical RNA silencing pathways. Efficacy of such a construct binding the Ci-Dll-B
pre-mRNA as a knock-down could therefore be tested using qRT-PCR to detect
whether it could lead to successful degradation of the Ci-Dll-B pre-mRNA. If so, no
amplification of Ci-Dll-B from cDNA derived from embryos electroporated with
DBsR would be expected. The DBsR construct was designed to drive expression of
the Ci-Dll-B antisense oligonucleotide under the control of the Irvine lab Ci-Dll-B
expression vector CiDB-2.5. CiDB-2.5 includes 2.5 kilobases of the Ci-Dll-B
upstream regulatory sequence capable of driving expression of lacZ in the entire wild
type Ci-Dll-B expression domain (Fig 2.3A).
Quantitative real time PCR analysis of DBsR. Confirmation of the efficacy of
the new constructs was performed using several methods. Since the mechanism
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employed by DBsR is expected to degrade the targeted pre-mRNA, attempts were
made to detect a reduction of Ci-Dll-B mRNA in embryos electroporated with DBsR
through qRT-PCR. The Ci-Dll-B target Ci-GATA-b for which suitable primers were
available was also tested in the expectation that reduced transcription would confirm a
successful knock-down of Ci-Dll-B.
To measure the effects of the DBsR construct upon expression of Ci-Dll-B and
the selected Ci-Dll-B regulatory target Ci-GATA-b using qRT-PCR, mRNA from
electroporated embryos was used as a template for cDNA synthesis. The cDNA was
then amplified using primers for target genes by qRT-PCR and relative expression
levels normalized using an average of the expression ratio of two housekeeping genes,
Ci-β-actin and Ci-calreticulin. After normalization to the control housekeeping genes,
embryos electroporated with DBsR unexpectedly showed a greater than 2-fold
increase in expression of Ci-Dll-B and Ci-GATA-b in in comparison to wild type
embryos (Fig. 2.4), a change large enough to indicate that the electroporated transgene
was responsible (Imai et al., 2006). This effect was seen at both doses of DBsR used in
electroporation. Attempts were also made to measure the levels of expression of the
Ci-Dll-B target gene Ci-FoxC, however these were unsuccessful due to lack of
priming.
Construction of CiDB-1.0::EnR/DllB (DBDN). The other knock-down
strategy employed made use of the powerful EnR repressor domain (Jaynes and
O’Farrell, 1991; Vickers and Sharrocks, 2002) fused with the Ci-Dll-B cDNA
sequence to produce a dominant negative form of Ci-Dll-B. This was cloned into an
expression vector which drives expression in the same cells as endogenous Ci-Dll-B.
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This construct was named CiDB-1.0::EnR/DllB (DBDN) (Fig. 2.5). Engrailed is a
homeobox transcription factor identified in Drosophila as a potent repressor. Its
repressor domain EnR is capable of silencing all activated expression, though not basal
transcription (Han and Manley, 1993). This indicates that the mechanism of repression
for EnR is a form of direct repression either disrupting the transcription pre-initiation
complex after it has been formed or interfering with its interaction with other
transcription activators. Due to the modular nature of proteins, it is possible to remove
the domain responsible for gene activation from a transcription factor protein and
convert it into a repressor by substituting a repressor domain without otherwise
disrupting its function. Previous studies have demonstrated that the EnR domain
produces a dominant negative phenotype used in this way (Jaynes and O’Farrell, 1991;
Vickers and Sharrocks, 2002). Furthermore it has already been shown that it can be
used for this purpose in ascidians (Katsuyama et al., 1999; Wada et al., 2002; Sawada
et al., 2005), including C. intestinalis (Spagnuolo and Di Lauro, 2002; Mita and
Fujiwara, 2007), as well as with Dlx vertebrate homologs (Woda et al., 2003). DBDN
was designed to produce a fusion protein of EnR and Ci-Dll-B under the control of the
Irvine lab Ci-Dll-B expression vector CiDB-1.0. CiDB-1.0 includes conserved
regulatory elements from genomic sequences 1.0 kilobase upstream of the Ci-Dll-B
gene that is capable of driving expression of lacZ in the entire wild type Ci-Dll-B
expression domain (Fig 2.3B).
To determine if the effects of the dominant negative construct could be
rescued, an overexpression rescue construct for the Ci-Dll-B gene was constructed.
This construct was named CiDB-1.0::DllB/VP16 (DBOE) (Fig. 2.6). This construct
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was used in co-electroporation experiments with the Ci-Dll-B dominant negative
construct in an attempt to restore the wild type phenotype in experimental embryos.
This strategy made use of the Herpes simplex viral protein 16 (VP16) activator
domain. VP16 is a strong transcriptional activator (Triezenberg et al., 1988), and its
activator domain has been shown to render transcription factors constitutive activators
when fused to the DNA binding domain (Sadowski et al., 1988). The mechanism by
which this promiscuous activator domain activates transcription is unknown, but it has
been shown to interact with components of the RNA polymerase II transcription preinitiation complex, including TBP (Shen et al., 1996) and the general transcription
factor TFIIB (Jonker et al., 2005). This suggests possible mechanisms for the VP16
activator such as contributing to the recruitment of the transcription pre-initiation
complex or shutting down autoinhibition of TBP (Hall and Struhl, 2002). It has
already been shown that the VP16 activator can be used to produce overexpression
constructs in ascidians (Wada et al., 2002; Sawada et al., 2005) and with Dll-B
vertebrate homologs (Woda et al., 2003). DBOE was designed to include a fusion
protein Ci-Dll-B and the VP16 activator domain under the control of CiDB-1.0 (Fig
2.3B).
Several additional constructs were produced to serve as controls for DBDN
and DBOE. To control for any effects of expression of the EnR domain alone upon the
embryos, the construct CiDB-1.0::EnR (DBEn) was produced (Fig. 2.7A). This
consisted of the EnR domain along with the backbone of the CiDB-1.0 construct.
CiDB-1.0::VP16 (DBVP) was produced for a similar reason to control for any effects
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of the VP16 domain alone upon the embryos (Fig 2.7B). It consisted of the VP16
activator domain along with the backbone of the CiDB-1.0 construct.
Semi-quantitative PCR analysis of DBDN. Expression of DBDN, DBOE, and
their associated control constructs was tested using semi-quantitative PCR. qRT-PCR
could not be used in the same manner as with DBsR due to the fusion protein nature
of the constructs being tested. Therefore the primers used for Ci-Dll-B detected both
endogenous transcript and the DBDN and DBOE constructs. Additional transcription
was expected to be detected from embryos expressing these constructs. Semiquantitative PCR was also used to detect for the expression of EnR and the VP16
activator. These were not expected to be expressed in wild type embryos, but instead
only in embryos where constructs containing these domains had been inserted through
electroporation.
Semi-quantitative PCR was performed on templates derived from DBDN and
the DBOE rescue construct to measure expression of Ci-Dll-B and the EnR and VP16
domains. For control purposes, the effects of DBEn and DBVP were also tested, as
well as the effects of each of these transgenes upon expression of Ci-β-actin as an
internal endogenous control. Electroporated treatments were prepared alongside each
other to express DBDN, DBOE, both DBDN and DBOE, DBEn, DBVP, or a control
construct confirmed to not affect the C. intestinalis wild type phenotype. RNA was
then extracted from the electroporated embryos for use as templates in semiquantitative PCR.
Embryos electroporated with at least one construct including the Ci-Dll-B
coding sequence showed increases in Ci-Dll-B expression compared to those which
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were not (Fig. 2.8). Embryos electroporated with constructs containing the EnR
sequence showed expression using EnR specific primers, unlike control embryos (Fig.
2.9). Embryos electroporated with constructs containing the VP16 activator sequence
showed expression using VP16 specific primers, unlike control embryos (Fig. 2.10).
Semi-quantitative PCR data demonstrated that the DBDN or DBOE transgenes
were being expressed as expected in electroporated embryos. Primers specific to the
EnR or VP16 activator domain were only able to amplify templates derived from
embryos where transgenes containing such domains were delivered through
electroporation. Alternatively, Ci-Dll-B specific primers displayed an increase in
detectable product with embryos electroporated with either DBDN or DBOE when
compared to control constructs when normalized using expression levels of Ci-β-actin.
This product could be due to either the endogenous Ci-Dll-B gene or the
electroporated transgenes. Even though DBDN was a knock-down construct, it
expressed the Ci-Dll-B coding sequence as part of a repressor fusion protein that is
meant to out-compete endogenous Ci-Dll-B. The amplification of EnR transcript
found in DBDN embryos and absent from control embryos indicated that expression
levels of Ci-Dll-B above control levels were due to transcription of this transgene.
Construction of a reporter transgene. To complement the Ci-Dll-B
expression vectors already available in the Irvine lab, the CiDB-5.0 expression vectorlacZ expression reporter construct was also produced (Fig 2.11). It consisted of
conserved regulatory elements from genomic sequences 5 kilobases upstream of the
Ci-Dll-B gene used to drive expression of lacZ. The expression pattern of lacZ under
the control of CiDB-5.0 is comparable to the pattern expressed by CiDB-2.5- and
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CiDB-1.0-based constructs while not disrupting the wild type phenotype (Fig. 2.3C).
Therefore CiDB-5.0 was suitable for use as a co-electroporation control. X-gal
histochemistry could be used to visualize regions of the embryo that had successfully
taken up and expressed the transgenes electroporated while control embryos could be
electroporated with CiDB-5.0 to control for the effects of this procedure without any
further phenotypic changes.
Additional transgenes used in this study. Several additional constructs were
used in this study but not produced by it. The Ci-Dll-B misexpression construct
dFoxAa::DllB (DBME) expresses Ci-Dll-B under the control of the promoter of CiFoxAa (Fig. 2.12). This promoter drives gene expression in mesodermal tissue where
Ci-Dll-B is not normally expressed. The dFoxAa::lacZ (DBFl) reporter construct
drives expression of lacZ under the same promoter, making it a suitable control
construct for comparison to DBME. The CiDB-1.0::RFP reporter construct drives
expression of a red fluorescent protein using the same promoter present in the CiDB1.0 vector. It could be visualized to confirm the efficacy of electroporation in embryos
where usage of X-gal histochemistry would interfere with further downstream
applications.
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Discussion
DBsR did not effectively silence Ci-Dll-B expression. Initial attempts were
made to silence Ci-Dll-B through use of the siRNA DBsR construct to bind the
splicing site of the first intron in the Ci-Dll-B pre-mRNA (Smith and Davidson, 2008).
Like Morpholinos this construct should act upon Ci-Dll-B mRNA to prevent
translation. qRT-PCR analysis of the effects of this construct was consistent with a
confounding autoregulation, showing an unexpected increase in expression of both CiDll-B and the previously identified downstream target Ci-GATA-b. This suggested that
removal of Ci-Dll-B at the transcriptional level might have removed a downregulatory signal ultimately acting directly or indirectly upon Ci-Dll-B. This might
have resulted in further expression of Ci-Dll-B that out-competed DBsR.
Alternatively, expression of DBsR may not have occurred as expected. Future studies
to understand the mechanism involved here could attempt could have been made to
verify transcription of DBsR, for example, by use of a Northern blot using a probe
specific for the siRNA sequence.
DBDN is an effective Ci-Dll-B dominant negative transgene. In order to
avoid any confounding effects from autoregulation that may have affected the siRNA
construct, a Ci-Dll-B/EnR fusion protein was produced. This alternative strategy was
pursued because it could compete with the endogenous protein at its regulatory
binding sites in the promoters of downstream targets, including its own autoregulatory
sites. Semi-quantitative PCR analysis of DBDN and its associated control constructs
was consistent with the expected expression of this transgene. Elevated levels of
amplification were detected using primers specific to the Ci-Dll-B sequence. This was
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due to the presence of this sequence in DBDN. The protein produced by this transcript
can bind DNA at the same places as endogenous Ci-Dll-B; however, due to the
presence of the EnR domain, it represses rather than activates expression of genes
which it binds. When present in sufficient quantity, this allowed it to out-compete the
endogenous protein and knock out the effects of its expression. A less likely
alternative source for the detected increase in Ci-Dll-B transcript was up-regulation of
endogenous Ci-Dll-B due to autoregulatory effects. Efforts by Imai et al. (2006) to
silence Ci-Dll-B gene expression using Morpholinos resulted in increased
transcription, suggesting that the Ci-Dll-B protein has a negative autoregulatory role.
Since Dlx genes typically act as transcriptional activators, it is unlikely Ci-Dll-B
would act directly as a repressor. Alternative mechanisms for autorepression could
include the recruitment of a transcriptional repressor by Ci-Dll-B, or for Ci-Dll-B to
compete for and block the DNA binding sites for factors that promote its transcription.
Autoregulatory scenarios in chordates are common, and include examples of simple
positive (Sato et al., 2012) or negative autoregulation (Brend and Holley, 2009), as
well as interactions with additional factors to modify the autoregulatory effect (Aota et
al., 2003; Ebert et al., 2003). Alternatively, the apparent negative autoregulation
detected by Imai et al. (2006) might have been an artifact of their screening method.
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Primer
DBDNintforward
DBDNintreverse
DBDNforward
DBDNreverse
DBOEintforward
DBOEintreverse
DBOEforward
DBOEreverse
DBEnforward
DBEnreverse
DBVPforward
DBVPreverse
CiDB5.0forwardA
CiDB5.0forwardB
CiDB5.0reverseA
CiDB5.0reverseB
DBsRforward
DBsRreverse
DBAnti+

DBAnti-

Sequence
5’- AACAAGGATCCGGCACGAGCACAACAGAG
5’-TAAGTACCGCGGAGTGAATGTTGCCGATAAAGG
5’-TACTTAGCGGCCGCAGGATTCATGGCCCTGGAGG
5'-AGCGACCGGCGCTCAGCAGTGAATGTTGCCGATAA
AGG
5’-AATACTCGAGGGCACGAGCACAACAGAG
5’-AACAAGGATCCTATTCGTTCGGATCGTAGTTG
5’-TACTTAGCGGCCGCTGGCACGAGCACAACAGAG
5’-ATCTAAGCTCAGCTATAGGGCGAATTGGACC
5'-CTCTGTTGTGCTCGTGCC
5'-GGCCTTTATCGGCAACATTCACT
5'-CTCTGTTGTGCTCGTGCC
5'-CAACATCGATCCGAACGAATA
5’- CGCGCCCTTTGTTTACTACCAAATGGGACG
5’- CCCTTTGTTTACTACCAAATGGGACG
5'- GCTCCCATCGGAGATTCAACGACG
5'- GGCCGCTCCCATCGGAGATTCAACGACG
5’- AACAAGGATCCGGCACGAGCACAACAGAG
5’- TAAGTACCGCGGAGTGAATGTTGCCGATAAAGG
5’- TTAAAAAAAGCGGTCATGAATGGTCCAATTTCAAAT
TTATTGACTGATGACTTTATTACGACTACTGTTTATTAC
TACGACGTGACAACGGACCGTAT
5’- ATACGGTCCGTTGTCACGTCGTAGTAATAAACAGTA
GTCGTAATAAAGTCATCAGTCAATAAATTTGAAATTGG
ACCATTCATGACCGCTTTTTTTAA

Table 2.1. Primers and oligonucleotides used to construct transgenes. Restriction
enzyme sites used in cloning are indicated in bold.
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Target

Forward Primer Sequence

Reverse Primer Sequence

Amplicon Size

Ci-Dll-B
Ci-βactin

5’-CAGTCAATACGAGCAAGTCG

5’-GGTTCCCCATCAAAATCTG

289 base pairs

5’-CTTCCTGACGGACAGGTTATCACC

5'-CTGTCGGCGATTCCAGGGAAC

212 base pairs

EnR
VP16

5’- ACGCCCTCCGCCTTTACAAGAG
5’- GAACTACCAACTCTACCAGCAGTC

5’- GCGACTCTGCACGATTTCCTCG
5’- CAGATCGAAATCGTCTAGCG

163 base pairs
188 base pairs

Table 2.2. Primers used for semi-quantitative polymerase chain reaction and
amplicon lengths.
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Primer
Ci-Dll-B Forward
Ci-Dll-B Reverse
Ci-GATA-b Forward
Ci-GATA-b Reverse
Ci-FoxC Forward
Ci-FoxC Reverse
Ci-β-actin Forward
Ci-β-actin Reverse
Ci-calreticulin Forward
Ci-calreticulin Reverse

Sequence
5’-CAGTCAATACGAGCAAGTCG
5’-GGTTCCCCATCAAAATCTG
5’-CTTGTGGCGAAGAAATGC
5’-AATCTCGGGTCCCTACATAC
5’-GGAAAAAGGGAGAAGTTGGATGCG
5’-TGGCAACCCCTGTTGAAGCG
5’-CTTCCTGACGGACAGGTTATCACC
5'-CTGTCGGCGATTCCAGGGAAC
5’-CCAATACAAAGGAAAGAACTTGCTC
5’-AGGAAGGAAGTCCCAATCGG

Table 2.3. Primers used for qRT-PCR analysis of DBsR.
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Figure 2.1. Diagram of the CiDB-1.0::EnR/DllB (DBDN) and CiDB1.0::DllB/VP16 (DBOE) intermediate constructs. These constructs were designed
as intermediate steps in cloning the final DBDN and DBOE constructs. Important
domains of the inserts for the final constructs are labeled. Blue indicates the Bluescript
backbones. Dark red indicates the engrailed repressor domain sequence. Yellow
indicates the endogenous Ci-Dll-B cDNA sequence with the DNA-binding homeobox
domain indicated. Green indicates the VP16 activator domain sequence. Restriction
enzyme sites located in the vector at the point of insertion for the Ci-Dll-B cDNA
sequence are labeled. A. DBDN intermediate. B. DBOE intermediate.
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Figure 2.2. Diagram of CiDB-2.5::siRNA (DBsR). This construct was designed to
silence Ci-Dll-B expression through expression of an siRNA that can degrade the CiDll-B pre-mRNA. Important domains are labeled. Black indicates the TV13 backbone
and the bent arrow indicates the promoter. Red indicates a 2.5 kilobase regulatory
domain that drives expression of this construct in the endogenous Ci-Dll-B expression
domain. Green indicates the siRNA insert that is antisense to the first intron/second
exon junction of Ci-Dll-B. DNA primer sites located in the vector at the point of
insertion for the siRNA sequence are labeled.
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Figure 2.3. Expression patterns of Ci-Dll-B reporter transgenes. Embryos shown
are at the mid-tailbud stage. Standard X-gal histochemistry was used to stain for
expression of the indicated reporter transgenes. Intensity of expression differs;
however, the overall lacZ expression pattern driven by these domains is the same as
wild type Ci-Dll-B. A. CiDB-2.5 expression pattern. B. CiDB-1.0 expression pattern.
C. CiDB-5.0 expression pattern.
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Figure 2.4. Quantitative real time PCR analysis of gene expression in embryos
electroporated with DBsR. Embryos were electroporated with DBsR in an attempt to
knock down expression of Ci-Dll-B and mRNA was then extracted to provide a qRTPCR template to compare expression relative to wild type embryos electroporated with
the reporter construct CiDB-2.5. Replicates were performed for each experiment in
duplicate and the results from replicates were averaged. Error bars indicate minimum
and maximum values for each gene. Differences in expression are shown on a log 2
scale. Red indicates a >2 fold increase in expression.
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Figure 2.5. Diagram of CiDB-1.0::EnR/DllB (DBDN). This construct was designed
to knock down Ci-Dll-B expression through expression of a dominant negative fusion
protein of Ci-Dll-B that can out-compete the endogenous protein. Important coding
(rectangular) and non-coding (rounded) domains are labeled. Black indicates the TV13
backbone and the bent arrow indicates the promoter. Red indicates a 1.0 kilobase
regulatory domain that drives expression of this construct in the endogenous Ci-Dll-B
expression domain. Dark red indicates the engrailed repressor domain sequence.
Yellow indicates the endogenous Ci-Dll-B cDNA sequence with the DNA-binding
homeobox domain indicated. Light blue indicates the SV40 nuclear localization
sequence. Restriction enzyme sites located in the vector at the point of insertion for the
EnR/Ci-Dll-B fusion protein are labeled.
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Figure 2.6. Diagram of CiDB-1.0::DllB/VP16 (DBOE). This construct was designed
to act as a constitutively active form of Ci-Dll-B and determine whether this could
rescue the effects of DBDN. Important coding (rectangular) and non-coding (rounded)
domains are labeled. Black indicates the TV13 backbone and the bent arrow indicates
the promoter. Red indicates a 1.0 kilobase regulatory domain that drives expression of
this construct in the endogenous Ci-Dll-B expression domain. Yellow indicates the
endogenous Ci-Dll-B cDNA sequence with the DNA-binding homeobox domain
indicated. Green indicates the VP16 activator domain sequence. Light blue indicates
the SV40 nuclear localization sequence. Restriction enzyme sites located in the vector
at the point of insertion for the Ci-Dll-B/VP16 fusion protein are labeled.
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Figure 2.7. Diagram of CiDB-1.0::EnR (DBEn) and CiDB-1.0::VP16 (DBVP).
These construct were designed to express the EnR or VP16 activator protein domains
respectively, and determine whether they had any phenotypic effects when not fused
to other proteins. Important coding (rectangular) and non-coding (rounded) domains
are labeled. Black indicates the TV13 backbone and the bent arrows indicate the
promoters. Red indicates a 1.0 kilobase regulatory domain that drives expression of
this construct in the endogenous Ci-Dll-B expression domain. Dark red indicates the
engrailed repressor domain. Green indicates the VP16 activator domain sequence.
Light blue indicates the SV40 nuclear localization sequence. Restriction enzyme sites
located in the vectors at the point of religation after the removal of the Ci-Dll-B cDNA
sequence are labeled. A. DBEn. B. DBVP.
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Figure 2.8. Semi-quantitative Polymerase chain reaction analysis of Ci-Dll-B
expression. Embryos were electroporated with the following transgenes: A. DBDN;
B. DBOE; C. rescue (DBDN & DBOE); D. DBEn; E. DBVP; F. wild type. mRNA
was then extracted and used as a semi-quantitative PCR template to compare relative
expression. Ci-β actin expression was measured to provide a control standard.
Embryos electroporated with transgenes in which Ci-Dll-B coding sequence is present
show elevated expression compared to wild type embryos and those electroporated
with transgenes in which it is absent. DBVP, a transgene including a constitutive
activator, produced more limited elevated expression.
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Figure 2.9. Semi-quantitative Polymerase chain reaction analysis of EnR
expression. Embryos were electroporated with the following transgenes: A. DBDN;
B. DBEn; C. wild type. mRNA was then extracted and used as a semi-quantitative
PCR template to compare relative expression. Ci-β actin expression was measured to
provide a control standard. EnR is not expressed in wild type embryos. EnR is
expressed in embryos electroporated with transgenes including this domain, but only
those that also include Ci-Dll-B show elevated expression of that gene.
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Figure 2.10. Semi-quantitative Polymerase chain reaction analysis of Ci-Dll-B
expression. Embryos were electroporated with the following transgenes: A. DBOE; B.
wild type; C. DBVP. mRNA was then extracted and used as a semi-quantitative PCR
template to compare relative expression. Ci-β actin expression was measured to
provide a control standard. VP16 activator domain is not expressed in wild type
embryos. VP16 activator domain is expressed in embryos electroporated with
transgenes including this domain, but only those that also include Ci-Dll-B show
elevated expression of that gene.
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Figure 2.11. Diagram of CiDB-5.0. This construct was designed to act as a reporter
driving expression of lacZ in the endogenous Ci-Dll-B expression domain. Important
coding (rectangular) and non-coding (rounded) domains are labeled. Black indicates
the TV13 backbone and the bent arrow indicates the promoter. Red indicates a 5.0
kilobase regulatory domain that drives expression of this construct in the endogenous
Ci-Dll-B expression domain. Blue indicates the lacZ gene. Light blue indicates the
SV40 nuclear localization sequence. Restriction enzyme sites located in the vector at
the point of insertion for the CiDB-5.0 upstream regulatory sequence are labeled.
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Figure 2.12. Diagram of dFoxAa::DllB (DBME). This construct was designed to
misexpress Ci-Dll-B under the control of an endo-mesodermal enhancer. Important
coding (rectangular) and non-coding (rounded) domains are labeled. Black indicates
the TV13 backbone and the bent arrow indicates the promoter. Red indicates the CiFoxAa regulatory domain that drives expression of this construct in the endogenous
Ci-FoxAa expression domain in the endo-mesoderm. Yellow indicates the endogenous
Ci-Dll-B cDNA sequence with the DNA-binding homeobox domain indicated. Light
blue indicates the SV40 nuclear localization sequence.
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CHAPTER THREE: ANALYSIS OF THE CI-DLL-B LOSS-OF-FUNCTION
AND MISEXPRESSION PHENOTYPES

Introduction
Several experiments were performed to determine the effects of Ci-Dll-B
misexpression and loss-of-function on the phenotype of the developing embryo and
upon expression of Ci-Dll-B targets already identified. Ci-Dll-B normally displays a
chordate specific ectodermal expression pattern starting at the 64 cell stage and
continuing in the ectodermal lineage into early gastrulation. This expression is due to
zygotic transcription as no maternal transcript of Ci-Dll-B is detected in this region
earlier; vegetal hemisphere expression is restricted to only a small number of cells
adjacent to the animal hemisphere. Several putative downstream regulatory targets that
Ci-Dll-B may be acting on at this stage have been identified by others (Imai et al.,
2006; Imai et al., 2012). These include Ci-Emx, Ci-FoxHa, Ci-FoxC, Ci-SOCS1/2/3,
Ci-GATA-b, Ci-SoxB2, and ci-ADMP. To determine the phenotype produced by the
DBDN construct, embryos were electroporated with this construct. Multiple doses of
transgene were attempted to determine the optimum dose for observing an effect and
to determine if the effect was dose dependent. Several additional constructs were also
electroporated alongside the dominant negative embryos for control purposes. These
included constructs with no phenotypic effect to produce wild type embryos that could
also control for the effects of electroporation. The DBEn and DBVP constructs were
used to determine that the protein domains they coded for lacked phenotypic effects
when not attached to a DNA binding domain. Finally, DBOE, which should act as a
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constitutively active form of Ci-Dll-B, was co-electroporated with CiDB1.0::EnR/DllB to determine whether the phenotype seen in the dominant negative
embryos could be rescued. Rescuing this phenotype was evidence that the effects seen
with DBOE are due specifically to perturbation of Ci-Dll-B. As these two constructs
were competing with each other, multiple dosage ratios were used to determine the
optimum dose for a rescue phenotype.
While examination of ectodermal cell structure was possible using light
microscopy without further modification of the embryos examined, examination of the
endo-mesoderm and expression of structural proteins required additional staining of
selected embryos. Staining with the actin binding mycotoxin phalloidin conjugated
with a fluorescent dye was used to visualize interior cells, particularly those of the
notochord to determine whether the Ci-Dll-B dominant negative construct had effects
on cells beyond those of the epidermis. Immunofluorescence for several structural
proteins with epidermal roles, including laminin and collagen, was used to visualize
more clearly the outlines of both epidermal cells and interior cells of selected
embryos, as well as to determine if any variation in expression could be seen for these
proteins. While less likely to be direct regulatory targets of Ci-Dll-B, such changes
provide clues for what sort of pathways might be under the control of Ci-Dll-B.
Another set of experiments was performed to see the effects on cell types and
cell behavior caused by ectopic expression of Ci-Dll-B in the endoderm and mesoderm
(Irvine, unpublished; Fig. 3.1). qRT-PCR was used to provide data to compare the
expression levels of selected genes of interest in embryos misexpressing Ci-Dll-B in
these germ layers with wild type embryos. In addition to Ci-Dll-B itself and Ci-FoxAa
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as an endo-mesodermal marker, expression of the epidermal marker Ci-epi1, and CiDll-B target Ci-GATA-b were tested to determine the extent to which cells
misexpressing Ci-Dll-B also expressed Ci-Dll-B targets, or had their endo-mesodermal
fates disrupted.
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Materials and Methods
Transgene construction and animal methods. Described in Chapter 2.
Phalloidin staining. Embryos were fixed in 2% formaldehyde/0.125%
glutaraldehyde in PTw (1x PBS; 0.1% Tween-20) for 10 min at room temperature,
then washed with PTw three times. Embryos were then permeablized by washing three
times with PBSTA (1X PBS/0.1% Triton X-100/50mM ammonium chloride), and
stained with 0.2U phalloidin-AlexaFluor 546 (Life Technologies, Carlsbad, CA)
previously dissolved in PBST (1X PBS/0.1% Triton X-100) for 2hr at room
temperature with rocking. Embryos were washed once for 10 min in PBSTT and three
times for 15 min each in PBS. Confocal imaging was performed using an LSM5
PASCAL microscope and Axioplan 2 imaging system (Carl Zeiss International,
Oberkochen, Germany).
Whole-mount in situ hybridization. Riboprobes were synthesized by in vitro
transcription from templates obtained from the Ciona gene collection (Ci-Dll-B clone
CiGC11g14, Ci-FoxC clone CiGC44e14, Ci-ADMP clone CiGC25f02, Ci-FoxHa
clone CiGC32f03, Ci-Epi1 clone CiGC25g21, and keratin clone CiGC32b24) (Satou
et al., 2002) or an arrayed Ciona cDNA library produced by P. Lemaire and coworkers (constructed by Cogenics, Meylan, France) (Ci-Emx clone VES83_F19, CiSOCS1/2/3 clone VES96_P07, Ci-GATA-b clone VES86_J23, and Ci-SoxB2 clone
VES83_F19) using digoxygenin-UTP (Roche, Indianapolis, IN) according to the
manufacturer’s instructions. Embryos were fixed in 4% paraformaldehyde (Electron
Microscopy Sciences, Hatfield, PA) in 3-(N-morpholino) propane sulfonic acid
(MOPS) buffer (0.1M MOPS, pH 7.5; 0.5M NaCl; 0.01% Tween-20) for 90 min at
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room temperature, or overnight at 4oC, then washed three times with PTw, rinsed with
water, washed in a graded ethanol series and stored in 100% ethanol at -20oC. To
prepare for hybridization, embryos were rehydrated through a graded ethanol series,
then washed three times with PTw. Embryos were permeabilized by incubation with 2
mg/ml Proteinase K (Ambion, Austin, TX) in PTw for 5 min for early stages through
neurula, or 9 min for tailbud stages. Digestion was stopped by washing twice with 2
mg/ml glycine in PTw, then embryos were post-fixed in 4% paraformaldehyde in PTw
for 30 min at room temperature. Specimens were acetylated in 0.26% acetic anhydride
in 1% triethanolamine by two washes of 5 min each, then washed three times with
PTw. Specimens were transferred to mobicol columns (MoBiTec, Gottingen,
Germany) for hybridization, washed once in a 1:1 mix of hybridization buffer/PTw,
then once in hybridization buffer and pre-hybridized in another change of
hybridization buffer at 60oC for 2 hr (hybridization buffer: 50% formamide; 5X SSC,
pH 4.5; 0.1% Tween-20; 2X Denhardt’s solution; 50 mg/ml heparin; 50 mg/ml yeast
RNA; 50 mg/ml sonicated herring sperm DNA). Riboprobes were denatured by
heating in hybridization buffer and added to the specimens to produce a final
concentration of 300ng/ml, and allowed to hybridize overnight at 60oC. The following
washes were performed at hybridization temperature for 20 min each: three times in
hybridization buffer; then one time each in 75% hybridization buffer/25% 2X SSC/Tw
(0.1% Tween-20); 50% hybridization buffer/50% 2X SSC/Tw; 25% hybridization
buffer/75% 2X SSC/0.1% Tween-20; then 2X SSC/0.1% Tween- 20; then three times
in 0.1X SSC/Tw. The next washes were performed at room temperature for 10 min
each: once each in 75% 0.1X SSC/Tw/25% PTw; 50% 0.1X SSC/Tw/50% PTw; 25%
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0.1X SSC/Tw/75% PTw; then twice in 100% PTw. Specimens were then washed
twice for 10 min in 2% Carnation instant milk in PTw, then blocked for 1 hr in the
same solution. Anti-digoxigenin antibody conjugated to alkaline phosphatase (Roche,
Indianapolis, IN) diluted in the above blocking solution was added to the specimens to
a final dilution of 1:5000 and incubated at 4oC overnight without rocking. The next
day the antibody was removed by washing out three times with blocking solution and
three times with PTw. The specimens were then transferred to 12-well plates and
washed twice in alkaline phosphatase detection buffer (100mM NaCl; 50mM MgCl;
100mM Tris, pH 9.5; 0.1% Tween-20). Signal was detected by incubating with nitro
blue tetrazolium chloride and 5-bromo-4-chloro-3-indolyl phosphate for from 24 hr to
3 days. Specimens were mounted in 70% glycerol/0.01% Tween-20 for photography
using an Olympus BX51 fluorescence DIC microscope and SPOT Flex Color imaging
system (SPOT Imaging Solutions, Sterling Heights, MI).
Immunofluorescence experiments. Embryos were fixed in 4%
paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA) in 3-(N-morpholino)
propane sulfonic acid (MOPS) buffer (0.1M MOPS, pH 7.5; 0.5M NaCl; 0.01%
Tween-20) for 90 min at room temperature, or overnight at 4oC, then washed three
times with PTw, rinsed with water, washed in a graded ethanol series and stored in
100% ethanol at -20oC. To prepare for hybridization, embryos were rehydrated
through a graded ethanol series, and then washed two times with PTw and once with
1X PBS. Specimens were transferred to mobicol columns (MoBiTec, Gottingen,
Germany) for staining, washed twice with PBS and once with water. Embryos were
permeabilized by washing with acetone and incubating 5 min at 4oC. Embryos were
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then washed once with water, once with PTw, and once with PBTT1 (1X PBS/0.4%
Triton X-100/0.2% Tween 20), then incubated 30 min at room temperature with
rocking in PBTT1. Embryos were then blocked by washing twice with PBT (1X
PBS/0.1% Triton X-100/2% BSA)/1% normal goat serum, then incubated 60 min in
the at room temperature with rocking in the same solution. Monoclonal primary
antibodies (Developmental Studies Hybridoma Bank, Iowa City, IA) diluted in the
above blocking solution was added to the specimens to a final dilution of 1:10 and
incubated at 4oC overnight without rocking. The next day the antibody was removed
by washing four times with PBT for twenty min AlexaFluor 488 conjugated donkey
anti-mouse IgG(H+L) (Life Technologies, Carlsbad, CA) diluted in PBT was added to
the specimens to a final dilution of 1:400 and incubated 60 min at room temperature
without rocking. Embryos were washed once in PBT 5 min, once in PBT 20 min,
twice in PBST (1X PBS/0.1% Triton X-100) 20 min, and once in PBST overnight at
4oC. The next day specimens were washed once with PBS for 5 min. Confocal
imaging was performed using an LSM5 PASCAL microscope and Axioplan 2
imaging system (Carl Zeiss International, Oberkochen, Germany).
Quantitative real time PCR. Embryos were electroporated with 50mg of DBFl
or DBME and reared to early tailbud stage (~9 hr at 18oC). RNA was extracted using
Nucleospin RNA XS (Macherey-Nagel, Dueren, Germany) according to the supplier’s
recommendations and cDNA synthesis performed using Affinity Script (Stratagene,
La Jolla, CA) according to the supplier’s recommendations using oligo-dT primers.
Quantitative analysis of mRNA levels was performed using a Brilliant II SYBR Green
(Stratagene, La Jolla, CA) assay in combination with the Mx3005P QPCR System
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(Stratagene, La Jolla, CA) according to the manufacturer’s protocols. Reactions were
set up and run in duplicate. Ci-β-actin and Ci-calreticulin were used as endogenous
controls. Primers were designed with MacVector 9.0 (MacVector Inc., Cary, NC),
except for Ci-β-actin primers (Kulman et al., 2006). Each sample was assigned a Ct
value indicating the PCR cycle at which detected fluorescent emission surpassed the
baseline. The collected data on target gene expression was normalized against an
average of Ci-β-actin and Ci-calreticulin expression using the program REST-MCS
version 2 (Pfaffl et al., 2002). For primers, see Table 3.1.
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Results
Analysis of the Ci-Dll-B dominant negative transgene phenotype. In order to
determine the phenotype associated with the Ci-Dll-B dominant negative construct and
the electroporation dosage required to obtain it, embryos were electroporated with
varying doses of DBDN. To ensure that DBDN was inserted into embryos as
expected, selected experimental batches were co-electroporated with the lacZ reporter
transgene CiDB-5.0. lacZ expression could then be visualized to determine which
embryos, as well as which cells within those embryos, were expressing the transgenes.
Embryos electroporated with DBDN showed a high incidence of disruption of outer
epidermal cells, particularly in the tail. This phenotype first became apparent by the
early tailbud stage (~9 hr post fertilization at 18oC) (Fig. 3.2). By the late tailbud stage
affected embryos showed a variety of phenotypes (Fig. 3.3) from disruptions of
individual cells in the epidermis leading to tail kinking (Fig. 3.3A) to cell adhesion
failure and blebbing of variable severity (Fig3.3B-D), to failure of the tip of tail to
properly form (Fig.3.3E), and to gross malformations of the tail including partial
forking (Fig. 3.3F). This effect was not found in embryos not electroporated with
DBDN (Fig. 3.3A) or co-electroporated with DBOE (Fig. 3.4B). Embryos
electroporated with the DBEn or the DBVP constructs likewise did not show this
effect (Fig. 3.4C-D).
Compared to embryos electroporated with a control reporter construct, DBDN
electroporated embryos showed a dosage dependent reduction in the wild-type
phenotype at the late tailbud stage (~14h hr post fertilization at 18oC or 24 hr post
fertilization at 13oC). Embryos were scored as affected if they showed visible defects
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in the epidermis or malformations attributable to such defects upon visual inspection
under 60X magnification dissecting microscopy and unaffected if they did not. An
increase in embryos affected in such a manner was present at all dosages of DBDN
tested over a range from 5µg to 100µg when compared to control embryos (Table 3.2,
Fig. 3.5). The range of severity of such phenotypes increased at doses of 40µg or
above, as did the average percentage of embryos displaying a phenotypic effect (Table
3.3, Fig. 3.6). Therefore, all further analysis of the dominant negative phenotype used
embryos from experiments that had been electroporated with a minimum of 40µg of
DBDN.
In order to see if a rescue phenotype could be recovered and to test the
specificity of the effects of DBDN, embryos were electroporated with the DBOE
overexpression construct in addition to DBDN dominant negative construct. As the
DBDN and DBOE constructs were competing with each other, it was necessary to
perform electroporations with both at differing ratios to determine the level where
their efficacy was comparable. Electroporation with a 1:1 ratio resulted in embryos
showing a more similar range of phenotypes to embryos electroporated with DBDN
alone than to wild type embryos (data not shown). Electroporation with a 2:1 ratio of
DBOE to DBDN showed a disrupted phenotype consistent with excessive uptake of
DNA, suggesting embryos were overloaded during electroporation. Reduction to a 3:2
ratio of DBOE to DBDN produced a rescue effect with the percentage of wild-type
embryos observed upon visual inspection under 60X magnification dissecting
microscopy in this treatment more similar to control embryos not electroporated with
DBDN (Table 3.3, Fig. 3.6).
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Ci-Dll-B dominant negative transgene produces a distinctive notochord
phenotype. In order to determine whether endodermal or mesodermal cell layers are
affected by reducing Ci-Dll-B expression in the normal domain, confocal microscopy
was performed on DBDN electroporated embryos stained with phalloidin to show cell
boundaries. Phalloidin staining showed a mosaic pattern of disruption in the
mesodermally derived notochord (Fig. 3.7). Most sections of the notochord formed a
single row of cells as expected in wild type embryos. Other sections did not form the
expected single row of cells, however. Disruption of notochord alignment could be
due to the disruption of signaling from the epidermis. This is in contrast to embryos
electroporated with a construct which expresses Ci-Dll-B in mesodermal tissue, where
disruption of the organization of the notochord is more extensive (Fig. 3.1).
Knock-down of Ci-Dll-B shows limited disruption of expression in known
downstream targets. To confirm the dominant negative phenotype of DBDN and
observe its effects upon previously identified downstream targets, whole mount in situ
hybridization (WMISH) was performed on embryos electroporated with DBDN to
visualize the expression of selected putative Ci-Dll-B targets as well as Ci-Dll-B itself.
The targets selected had been identified by Imai et al. (2006) by knocking down gene
expression of Ci-Dll-B at the post-transcriptional level using Morpholinos. Effects on
the expression of genes downstream were then measured by qRT-PCR. These
experiments indicated that Ci-Dll-B is an activator of the target genes (Fig. 1.5).
DBDN would be expected to have a similar down-regulatory effect on these genes,
though the presence of maternally derived transcripts of the genes probed could
potentially have a confounding effect.
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Digoxygenin labeled RNA probes were prepared for WMISH. Templates for
probes for Ci-Dll-B transcripts, transcripts of previously identified Ci-Dll-B regulatory
targets, or transcripts of epidermal marker genes were prepared from cDNA templates
isolated from either the Ciona gene collection (Satou et al., 2002), or an arrayed Ciona
cDNA library produced by P. Lemaire and co-workers (constructed by Cogenics,
Meylan, France). Ci-Dll-B, Ci-SOCS1/2/3, Ci-GATA-b, Ci-FoxHa, Ci-SoxB2, and CiEmx were successfully isolated. Attempts to isolate Ci-FoxC, ci-ADMP, and the
epidermal markers Ci-Epi1 and keratin were unsuccessful.
DBDN and control construct embryos were hybridized with the successfully
prepared probes, and then hybridized embryos were incubated with alkaline
phosphatase conjugated anti-digoxygenin antibody. These embryos were treated with
AP substrate to produce colorimetric staining of localized Ciona intestinalis gene
expression. Based on preliminary results, genes without maternal transcript present
such as SoxB2 (Satou et al., 2005) or with directly observed quantitative reduction in
expression by Morpholino knock-down of Ci-Dll-B (Imai et al., 2006) such as Ci-Emx
and Ci-SOCS1/2/3 were chosen for further testing, in addition to Ci-Dll-B itself. All
WMISH embryos were compared to stained negative control embryos to determine the
level of background staining (Fig. 3.8). Compared to control embryos, DBDN
electroporated embryos showed increased expression levels of transcripts hybridizing
to the Ci-Dll-B probe at all stages analyzed (Fig. 3.9). Among known Ci-Dll-B targets,
there was little apparent effect on the level of expression of Emx (Fig. 3.10) or CiSOCS-1/2/3 (Fig. 3.11), which was already being expressed by the late gastrula stage
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(~6 hr post fertilization at 18oC) (Fig. 3.11A-B). However, expression of Ci-SoxB2
was reduced in DBDN embryos, particularly at later stages (Fig. 3.12).
Immunohistochemical analysis shows alteration in collagen and laminin
expression. Because it appeared that the proper organization of the epidermal
epithelium was disrupted in Ci-Dll-B dominant negative (DBDN) embryos, the extracellular matrix (ECM) proteins collagen and laminin were examined by
immunofluorescence. DBDN and control embryos were subjected to
immunohistochemistry using the mouse monoclonal antibodies M3F7 (anti-collagen),
SP1.D8 (anti-collagen), or D18 (anti-laminin). Embryos treated with the M3F7 anticollagen or anti-laminin antibodies showed fluorescent staining in contrast to embryos
treated with the secondary antibody only (Fig. 3.13); however, the SP1.D8 anticollagen antibody did not show apparent reaction with C. intestinalis embryos. Signal
detected from DBDN electroporated embryos was more intense than from wild type
embryos (Fig. 3.13). This was potentially due to the greater visibility of endomesodermal cells expressing collagen and laminin in these embryos, or alternatively to
increased production of these proteins due to the effects of the Ci-Dll-B knock-down
construct. This result suggests that Ci-Dll-B attenuates expression of these ECM
proteins. Interestingly, DBDN electroporated embryos showed an apparent reduction
in the size of cells present in the epidermis compared to wild type embryos (Fig.
3.13A-B), suggesting that reduction of Ci-Dll-B expression has an effect on epidermal
cell growth.
Quantitative real time PCR analysis of Ci-Dll-B misexpression. To determine
if expression of Ci-Dll-B in ectopic domains affects cell type or behavior, the DBME
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transgene was used to drive transcription of Ci-Dll-B in the endoderm and mesoderm,
where it is normally absent. qRT-PCR was then used to compare expression levels of
genes of interest between embryos electroporated with DBME and those
electroporated with the reporter construct DBFl, as a control. mRNA from
electroporated embryos was used as a template for cDNA synthesis. The resulting
cDNA was amplified using primers for target genes by qRT-PCR and relative
expression levels normalized using an average of the expression ratio of two
housekeeping genes, Ci-β-actin and Ci-calreticulin. Ci-Dll-B was substantially upregulated in the misexpression construct (Fig. 3.14), while the endo-mesodermal
marker Ci-FoxAa and the known Ci-Dll-B target Ci-GATA-b were down-regulated
(Fig. 3.14). This result suggests that Ci-Dll-B is capable of directly or indirectly
activating Ci-FoxAa and Ci-GATA-b transcription. Ct values assigned to raw
fluorescence indicated that expression levels of Ci-GATA-b were lower than the other
mRNAs tested (Table 3.4). Interestingly, levels of expression for the epidermal marker
gene Ci-Epi1 were similar between experimental and control embryos (Fig. 3.14).
This result suggests that misexpression of Ci-Dll-B in the endoderm or mesoderm does
not broadly alter the fates of the cell types present there.
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Discussion
Knock-down of Ci-Dll-B disrupts normal epidermal assembly. Knock-down
of the effects of Ci-Dll-B expression using a dominant negative construct resulted in
disruption of the outer epidermal cell layers of C. intestinalis embryos. This disruption
was most apparent in the tail and was first detectable as the tail began lengthening.
Although endogenous pan-ectodermal Ci-Dll-B transcript expression occurs at an
earlier stage, as a transcription factor Ci-Dll-B affects the expression of genes
responsible for epidermal patterning at a later stage. Therefore a delay in the
appearance of a phenotypic effect would be expected.
Comparison of the phenotypes produced by the DBDN and control constructs
showed that DBDN was responsible for the observed phenotypic changes in the
epidermis (Fig 3.3) while the EnR sequence could not produce this phenotype by itself
(Fig 3.4C). When co-electroporated with DBOE, embryos showed phenotypes
comparable to wild-type embryos or those electroporated with constructs known not to
phenotypically affect C. intestinalis (Fig. 3.4A-B). As the repressor properties of EnR
(Vickers and Sharrocks, 2002) and the activator properties of VP16 (Sadowski et al.,
1988) are both well documented, these effects were consistent with the expectation
that DBDN would out-compete and repress the effects of endogenous Dll-B
expression, and demonstrated that the VP16 activator domain has the ability to rescue
the effects of EnR. Since the expression of the EnR domain alone had no phenotypic
effect upon epidermal morphology, it was concluded that the effects observed here
were due to the fusion of EnR to the sequence-specific DNA binding protein Ci-Dll-B.
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Ci-Dll-B dominant negative and misexpression phenotypes are distinct. The
DBDN transgene caused disruption of the epidermal epithelium of the tail. On the
other hand, mesodermally derived cells such as the notochord usually retained their
normal organization (Fig. 3.7). This was in contrast to the effects of misexpression of
Ci-Dll-B in endo-mesodermal tissues, using the construct DBME, where the
disruptions seen in endo-mesodermal tissues were more severe (Fig. 3.1). While CiDll-B is normally expressed only in the ectoderm, its putative targets include genes
associated with cell-cell signaling pathways including SOCS1/2/3 (Imai et al., 2006)
and ADMP (Imai et al., 2012). It is therefore possible that while the primary role of
Ci-Dll-B is in the epidermis, it could have a secondary role through cell-cell signaling
in the correct assembly of cells in the vicinity of the epidermis such as the notochord.
It is also possible that overexpression of Ci-Dll-B in endo-mesodermal tissues may
disrupt correct notochord assembly by affecting ECM proteins, as was seen in
embryos electroporated with DBDN (Fig. 3.13).
qRT-PCR analysis of DBME misexpression showed down-regulation of endomesodermal genes without up-regulation of epidermal genes, suggesting a disruption
of normal endo-mesodermal patterning without respecification of these cells into
ectodermal roles. The up-regulation of Ci-Dll-B expression in embryos with the
DBME fusion transgene compared to control embryos indicated that this transgene
was indeed functioning as a misexpression construct, increasing Ci-Dll-B mRNA
levels in presumptive endo-mesoderm where Ci-Dll-B is normally inactive. As CiEpi1 is an epidermal marker, the lack of change in its expression level indicated that
misexpression of Ci-Dll-B was not sufficient to respecify presumptive endo-mesoderm
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as epidermis. This suggests that expression of an additional factor is necessary for
epidermis specification, or, alternatively, that an unknown factor was antagonizing CiDll-B in the endo-mesoderm. The finding that Ci-GATA-b was down-regulated by the
misexpression construct contradicted earlier findings that Ci-GATA-b is a Ci-Dll-B
regulatory target. However, the low levels of Ci-GATA-b mRNA detected here (Table
3.4) are consistent with the possibility that this result was the sort of technical error to
which qRT-PCR is sensitive.
DBDN has limited effects on expression of putative Ci-Dll-B targets.
WMISH analysis conducted here of the expression of previously identified (Imai et
al., 2006) Ci-Dll-B targets showed only minimal disruption of the regulation of these
target genes caused by Ci-Dll-B knock-down. Ci-Dll-B appeared to show an increase
in expression; however, this was due to the expression of the dominant negative
construct, which includes the Ci-Dll-B cDNA sequence. A less likely source for this
detected increase in Ci-Dll-B transcript was up-regulation of endogenous Ci-Dll-B due
to autoregulatory effects (see Chapter 2). While a clear reduction of expression levels
of Ci-SoxB2 could be seen, levels of Ci-SOCS1/2/3 and Ci-Emx did not appear
affected. These results suggest that the dominant negative form of Ci-Dll-B did not
reduce the expression levels of these genes; however, WMISH is not quantitative.
Additional analysis of these genes in Ci-Dll-B knock-down embryos by qRT-PCR
could be performed to confirm this.
The failure to detect a reduction in the expression level of several putative CiDll-B targets by WMISH suggests a degree of redundancy in the regulation of most
genes in the epidermal patterning program. This could be due to the effects of an
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additional factor that can compensate for the absence of Ci-Dll-B or by the presence of
maternally derived transcripts of known Ci-Dll-B targets. Notably, previous in situ
hybridization analysis of wild type expression of Ci-Dll-B target genes showed the
presence of maternally derived transcripts of Ci-SOCS1/2/3 and Ci-Emx (Satou et al.,
2005). No such maternal expression was apparent in the case of Ci-SoxB2, suggesting
that its expression is more sensitive to disruption of zygotic transcription. Maternal
transcripts of Ci-Dll-B have also been detected (Caraciolo et al., 2000); however, these
were spatially restricted to the posterior end of the embryo and are therefore unlikely
to be able to compensate for a knock-down of expression across the broader
expression domain of Ci-Dll-B. The possibility of regulatory redundancy was further
suggested by the dose-dependent nature of phenotypic disruption by Ci-Dll-B knockdown (Table 3.2; Table 3.3; Fig. 3.5; Fig. 3.6). A greater percentage of embryos
displayed an unaffected phenotype when electroporated with lower doses of the
transgenic dominant negative construct, while even at higher doses a percentage of
embryos remained unaffected and affected ones still displayed a range of severity of
phenotypes. While functional overlap between clustered genes is a common source of
redundancy in the Dll gene family, this is unlikely to account for the results obtained
in this study as, unusually for a Dll bigene cluster, the expression domain of the cluster
partner Ci-Dll-A does not overlap that of Ci-Dll-B either spatially or temporally,
including in the epidermal domain (Irvine et al., 2007).
Comparison of Ci-Dll-B function with vertebrate homologs. Analysis of
ECM proteins by immunofluorescence demonstrated that epidermal ECM proteins
such as collagen and laminin remained present in the outer cell layers even after
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knock-down of Ci-Dll-B, although their expression may have been disrupted (Fig.
3.13). Normal organization was disrupted and cells continued to maintain an
epidermal fate; disruption appeared to affect tissue morphogenesis rather than basic
cell type specification. This was again consistent with the evidence of Ci-Dll-B
affecting the fate of cells already specified as epidermis at a later stage of their
development.
The results of this study were consistent with earlier analyses of the expression
of Ci-Dll-B gene homologs in vertebrates. Mutation of the DLX3 gene in humans is
associated with conditions characterized by malformations of tissues derived from
developmental interactions between epithelial and mesenchymal cells. Tricho-dentoosseous syndrome is characterized by malformations to the hair, teeth, and bones and
is associated with a nonfunctional frameshift mutation of DLX3 (Price et al., 1998).
Ankyloblepharon-ectodermal dysplasia-clefting dysplasias are characterized by the
reduction or absence of hair, teeth, and skin glands and are associated with alteration
of DLX3 expression due to mutation of an upstream regulator (Radoja et al., 2007).
The phenotypic effects of altered Dlx expression typically limited to tissue
morphogenesis rather than basic cell type specification or alteration of body plan
patterning. Misexpression of Dlx family genes in vertebrates does not result in major
alterations to limb morphology (Morasso et al., 1996). Although they are necessary
factors for proper epidermal development, Dlx homologs in vertebrates are not
sufficient to specify an epidermal cell fate (Feledy et al., 1999a; McLarren et al., 2003;
Woda et al., 2003). However, malformation of the epidermis (Morasso et al., 1996;
Hwang et al., 2011) and epidermally derived tissues such as hair (Hwang et al., 2008)
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and feathers (Rouzankina et al., 2004) is common. Moreover, loss-of-function of the
Dlx3 gene in Xenopus can disrupt the fates of non-epidermal cell populations
interacting with the epidermis, including the neural plate, neural crest, and cranial
placodes (Woda et al., 2003).
Analysis of misexpression and loss-of-function of Dlx family genes in multiple
vertebrate lineages indicates that Dlx homolog expression in the epidermis has
proliferative and differentiative roles. In mice, premature differentiation of epidermal
cells into keratinocytes resulting from Dlx3 misexpression has been shown to produce
defects of variable severity in the terminally differentiated epidermis, characterized by
the disappearance of cell layers in the stratum corneum (Morasso et al., 1996).
Furthermore, it appears Dlx3 misexpression or overexpression causes premature
differentiation in the epidermis. In this case, alterations in the levels of expression of
epidermal markers associated with different epidermal cell populations are consistent
with premature differentiation depleting the supply of cells for later differentiating cell
types. Loss-of-function results in a hyperproliferation of cells and changes in
epidermal marker expression suggestive of changes in wild type cell differentiation
(Hwang et al., 2011). The resulting epidermis is abnormal and fails to form a proper
barrier. Dlx homologs also play roles in differentiation of hair and feathers, which are
derived from the epidermis, but these roles are dissimilar. Dlx3 is necessary for the
induction of hair follicle growth from the initial proliferating cell population in mice
(Hwang et al., 2008), whereas Dlx2 and Dlx5 activate factors that inhibit the formation
of feather buds (Rouzankina et al., 2004).
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Comparison with vertebrate homologs suggests that phenotypic effects of CiDll-B misexpression and loss-of-function are not related to alteration of cell fates
between epidermal and non-epidermal tissue, but rather to disruption of differentiation
of cell types within these lineages. In particular, malformations of the epidermis such
as the disruption of normal cell layers could be the result of alterations to the
differentiation of the cells that would normally form them. The results of Dlx homolog
perturbation seen in vertebrates suggest that Ci-Dll-B knock-down prevents terminal
epidermal differentiation and produces continued proliferation of cells incapable of
forming effective barrier layers. This would be consistent with the observation of
decreased cell size and disruption of cell layers seen in Ci-Dll-B knock-down embryos
(Fig. 3.13).
The reduction of Ci-SoxB2 expression, observed here in Ciona, is also
consistent with this hypothesis, as the SoxB gene family has conserved roles in the
regulation of cell proliferation and differentiation as well as of cell adhesion (Guth and
Wegner, 2008). However, Ci-SoxB2 is unlikely to be involved directly in the
establishment of this phenotype because a reduction in its expression is not apparent
until after disruption of the epidermis is first apparent (Fig. 3.12). The phenotype
observed in this study differs from the knock-down of Danio rerio sox21a, a zebrafish
SoxB2 homolog, which results in ventralization of the developing embryo (Argenton
et al., 2004). However, Dr-sox21a is maternally expressed, while Ci-SoxB2 expression
is first seen during gastrulation. Due to the teleost fish-specific genome duplication, D.
rerio has an additional SoxB2 homolog, Dr-sox21b. This gene is not expressed until
late in gastrulation, which could make it a more likely functional homolog for Ci-
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SoxB2. Dr-sox21b is necessary for lens development (Pauls et al., 2012). This suggests
the possibility of regulation of Dr-sox21b by a Dll homolog, due to their frequent roles
in sensory expression. Since Dll-B does not appear to have a sensory role in C.
intestinalis (Irvine et al., 2007), the function of Dll regulation of SoxB in tunicates
may differ from that in teleost fishes, the vertebrate lineage where SoxB homologs
have been most studied.
Whether the alteration of cell fates is responsible for the observed phenotype
might be determined by further analysis of differentiated epidermal markers. Since the
use of mouse derived antibodies to detect C. intestinalis structural proteins in this
study was successful, this analysis could be accomplished through the continuation of
such immunofluorescence experiments. Loricrin and filaggrin are two markers of
differentiated epidermal tissue (Fuchs and Byrne, 1994) that would be strong
candidates for observation. Misexpression of Xenopus Dlx3 in mice has been shown to
cause ectopic production of these proteins (Morasso et al., 1996). Changes in the
expression of these factors would be evidence that epidermal cell differentiation has
been altered. If confirmed, this would provide new insight into the specific function of
Ci-Dll-B within the differentiation of the epidermis and would imply a similar
function for early ectodermal expression as that seen in other chordates.
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Primer
Ci-Dll-B Forward
Ci-Dll-B Reverse
Ci-GATA-b Forward
Ci-GATA-b Reverse
Ci-FoxAa Forward
Ci-FoxAa Reverse
Ci-Epi1 Forward
Ci-Epi1 Reverse
Ci-β-actin Forward
Ci-β-actin Reverse
Ci-calreticulin Forward
Ci-calreticulin Reverse

Sequence
5’-CAGTCAATACGAGCAAGTCG
5’-GGTTCCCCATCAAAATCTG
5’-CTTGTGGCGAAGAAATGC
5’-AATCTCGGGTCCCTACATAC
5’-ACACCCATGCTAAGCCAG
5’-TTTGCCAGGTTTGTCTGC
5’-TGGATTTGGTAACGACGC
5’-CCTTGTTGTGCGAGAATG
5’-CTTCCTGACGGACAGGTTATCACC
5'-CTGTCGGCGATTCCAGGGAAC
5’-CCAATACAAAGGAAAGAACTTGCTC
5’-AGGAAGGAAGTCCCAATCGG

Table 3.1. Primers used for qRT-PCR analysis of DBME.
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Mass of DNA electroporated Experimental percentage affected n ( exp. embryos) Control percentage affected n (ctrl. embryos) n (experiments)

5ug
10ug
20ug
25ug
30ug
40ug
50ug
100ug

55.0%
72.0%
75.7%
84.6%
73.7%
84.8%
83.3%
86.2%

100
286
226
13
137
330
54
65

19.4%
22.2%
30.8%
62.1%
40.9%
28.8%
36.9%
46.5%

36
667
234
29
357
546
236
127

1
4
2
1
3
4
3
2

Table 3.2. Percentages of embryos phenotypically affected after electroporation
with DBDN. Newly fertilized embryos were electroporated with either varying doses
of the DBDN Ci-Dll-B knock-down construct over a range from 5µg to 100µg or a
control reporter construct without a phenotypic effect. Embryos were reared to the late
tailbud stage (~18hr at 18oC or ~24hr at 13oC) and scored as displaying either an
affected phenotype or an unaffected wild type phenotype. If multiple experiments
were performed at the same dose, percentages were averaged.
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Treatment
DBDN < 40µ
µg
DBDN ≥ 40µ
µg
Rescue
Control

Percentage
Unaffected

Percentage
Affected
32.0%
20.6%
56.1%
60.9%

Standard
Deviation
68.0%
79.4%
43.9%
39.1%

19.1%
17.0%
18.0%
15.3%

n
Experiments
8
5
4
9

Table 3.3. Mean percentages of embryos phenotypically affected after
electroporation. Newly fertilized embryos were electroporated with either a low dose
of DBDN (< 40µg), a high dose of DBDN (≥ 40µg), a rescue treatment (both DBDN
and DBOE), or a control reporter construct without a phenotypic effect. Embryos were
reared to the late tailbud stage (~18hr at 18oC or ~24hr at 13oC) and scored as
displaying either an affected phenotype based on disruption to the morphology of the
tail or an unaffected wild type phenotype. Percentages were averaged over several
experiments within each range.
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Treatment
Ci-Beta Actin Ci-Calreticulin Ci-Dll-B Ci-Epi1 Ci-FoxAa Ci-GATA-b
Misepxression (DBME)
19.03
22.45
23.72
21.44
25.53
31.34
18.94
22.21
23.81
20.14
25.53
40.00
Wild Type (DBFl)
21.85
25.09
30.77
23.82
27.22
35.30
21.73
25.33
30.83
23.62
27.15
35.30

Table 3.4. Pre-normalized Ct values of real time quantitative PCR analysis of
gene expression in embryos misexpressing Ci-Dll-B. Reactions were performed in
duplicate and the cycle where fluorescence first met a threshold figure was recorded.
A value of 40.00 indicates that the threshold was never met. Higher values indicate a
lower initial template copy number. The values measured for Ci-β Actin and Cicalreticulin were used to normalize experimental Ct values and find the relative
difference in expression levels.
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Figure 3.1. Effects of Ci-Dll-B misexpression upon the developing notochord.
Embryos in (b, e, h) were treated with phalloidin conjugated to AlexaFluor 546 to
show cell outlines. (a, b) Typical control embryos in lateral view with anterior to the
right, electroporated with the DBFl transgene. The notochord is indicated by the white
arrowhead. (c-h) Embryos co-electroporated with DBFl and DBME transgenes. (c)
Globular phenotype (2 focal planes separated by the white line) with twinned
notochords (arrowheads). (d, e) Short tail phenotype with "split" notochord
(arrowheads and white dotted outline). Globular embryo (f, anterior to the left) has a
notochord extending abnormally far to the anterior in the trunk (dotted outline, stained
for acetylcholinesterase). (g, h) Short tail phenotype with incompletely converged
notochord (arrowheads) with anterior to the left. Photo (g) is taken at 2 focal planes
separated by the white line (from Irvine et al., unpublished).
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Figure 3.2. Comparison of CiDB-1.0::EnR/DllB (DBDN) and wild type
phenotypes at the early tailbud stage. A. Embryos were electroporated with DBDN
and reared to the early tailbud stage (~9hr at 18oC). At this stage defects were apparent
in the developing epidermis. Individual cells (indicated by arrowheads) failed to
adhere properly in the formation of this layer, especially in the tail (shown). The
embryo is stained with alkaline phosphatase substrate to show expression of the
epidermal marker and Ci-Dll-B regulatory target Ci-SoxB2. B. Unaffected wild type
embryo for comparison. The embryo is stained with alkaline phosphatase substrate to
show expression of Ci-Dll-B.
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Figure 3.3. DBDN phenotypes at the late tailbud stage. Embryos were
electroporated with DBDN and reared to the late tailbud stage (~18hr at 18oC or ~24hr
at 13oC). Affected embryos displayed a range of phenotypes including: (A) kinks in
the tail; (B, C, D) cell adhesion failure and blebbing of variable severity; (E) failure of
the tip of tail to properly form; and (F) forking of the tail. lacZ staining indicates the
presence of the reporter construct CiDB-5.0, coelectroporated with DBDN and
expressed in the same cells as DBDN would be.
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Figure 3.4. Phenotypes of control embryos for DBDN. Some control embryos
displayed alterations in phenotype due to the effects of dechorionation or
electroporation; however, alterations of phenotypes characteristic of DBDN
expression are absent. A. Rescue embryo co-electroporated with both DBDN and
DBOE. Phenotypes displayed by these embryos were comparable to the wild type. B.
Wild type late tailbud embryo. C. Phenotype of embryo expressing CiDB-1.0::EnR
(DBEn) (focal planes separated by the white lines). Staining of lacZ expression driven
by CiDB-5.0 indicates the expression domain of Ci-Dll-B. D. Phenotype of embryo
expressing CiDB-1.0::VP16 (DBVP).
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Figure 3.5. Graph of percentages of embryos phenotypically affected after
electroporation with DBDN. Newly fertilized embryos were electroporated with
either varying doses of the DBDN Ci-Dll-B knock-down construct over a range from
5µg to 100µg or a control reporter construct without a phenotypic effect. Embryos
were reared to the late tailbud stage (~18hr at 18oC or ~24hr at 13oC) and scored as
displaying either an affected phenotype or an unaffected wild type phenotype. If
multiple experiments were performed at the same dose, percentages were averaged.
Error bars indicate minimum and maximum values when more than one experiment
was performed.

79

Figure 3.6. Graph of mean percentages of embryos phenotypically affected after
electroporation. Newly fertilized embryos were electroporated with either a low dose
of the DBDN Ci-Dll-B knock-down construct (< 40µg), a high dose of the DBDN CiDll-B knock-down construct (≥ 40µg), a rescue treatment (both DBDN and DBOE), or
a control reporter construct without a phenotypic effect. Embryos were reared to the
late tailbud stage (~18hr at 18oC or ~24hr at 13oC) and scored as displaying either an
affected phenotype or an unaffected wild type phenotype. Percentages were averaged
over several experiments within each range. Error bars indicate standard deviation for
each treatment.
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Figure 3.7. Effects of Ci-Dll-B knock-down upon the developing notochord.
Embryos were treated with phalloidin conjugated to AlexaFluor 546 to show cell
outlines. Anterior is at the bottom right and posterior is at the top left. A. Late tailbud
embryo electroporated with CiDB-1.0::EnR/DllB (DBDN). Arrowheads indicate
notochord cells showing mosaic disruption, but they do not show phenotypes
characteristic of Ci-Dll-B misexpression in endo-mesodermal tissue. B. Wild type
embryo.
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Figure 3.8. Whole mount in situ hybridization no probe control embryos. Wild
type no probe control embryos were colorimetrically stained with AP substrate to
determine the level of background staining for comparison with stained, probed
embryos.
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Figure 3.9. Effects of Ci-Dll-B knock-down upon Ci-Dll-B expression. Whole
mount in situ hybridization analysis for Ci-Dll-B was performed on embryos
electroporated with CiDB-1.0::EnR/DllB (DBDN) and wild type embryos collected at
several stages of development. After probing for Ci-Dll-B, digoxygenin labeled probes
were bound with alkaline phosphatase labeled antibody and visualized. DBDN
electroporated embryos show greater expression at all stages (A, C, E) than the wild
type (B, D, F).
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Figure 3.10. Effects of Ci-Dll-B knock-down upon Ci-Emx expression. Whole
mount in situ hybridization analysis for Ci-Emx was performed on embryos
electroporated with CiDB-1.0::EnR/DllB (DBDN) and wild type embryos collected at
the late tailbud stage of development. After probing for Ci-Emx, digoxygenin labeled
probes were bound with alkaline phosphatase labeled antibody and visualized. DBDN
electroporated embryos (A) show comparable expression at the late tailbud stage with
the wild type (B) (focal planes separated by the white line).
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Figure 3.11. Effects of Ci-Dll-B knock-down upon Ci-SOCS1/2/3 expression.
Whole mount in situ hybridization analysis for Ci-SOCS1/2/3 was performed on
embryos electroporated with CiDB-1.0::EnR/DllB (DBDN) and wild type embryos
collected at several stages of development. After probing for Ci-SOCS1/2/3,
digoxygenin labeled probes were bound with alkaline phosphatase labeled antibody
and visualized. DBDN electroporated embryos show comparable expression at all
stages (A, C, E) (focal planes separated by the white line) with the wild type (B, D, F).
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Figure 3.12. Effects of Ci-Dll-B knock-down upon Ci-SoxB2 expression. Whole
mount in situ hybridization analysis for Ci-SoxB2 was performed on embryos
electroporated with CiDB-1.0::EnR/DllB (DBDN) and wild type embryos collected at
several stages of development. After probing for Ci-SoxB2, digoxygenin labeled
probes were bound with alkaline phosphatase labeled antibody and visualized. DBDN
electroporated embryos (A) show comparable expression at the early tailbud stage
with the wild type (B), but show reduced expression at the late tailbud stage (C) than
the wild type (D).
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Figure 3.13. Effects of Ci-Dll-B knock-down upon epidermal markers and cell
morphology. Embryos electroporated with DBDN and wild type embryos were
collected at the late tailbud stage and incubated with antibodies specific to collagen or
laminin. Embryos were then incubated with a secondary antibody conjugated with
Alexafluor 488 and visualized. A-D. Comparison of DBDN electroporated and wild
type embryos incubated with the M3F7 anti-collagen antibody at 20X (A-B) and 40X
(C-D) magnification. Staining indicates an alteration of cell shape in both ectoderm
and mesoderm and potential alteration in expression of collagen. Arrowheads in A-B
indicate individual cells for comparison. E-F. Comparison of DBDN electroporated
and wild type embryos incubated with the D18 anti-laminin antibody. Staining
indicates an alteration of cell shape in both ectoderm and mesoderm and potential
alteration in expression of laminin. G. DBDN electroporated embryo incubated with
the Alexafluor 488 conjugated secondary antibody only as a negative control.
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Figure 3.14. Quantitative real time PCR analysis of gene expression in embryos
misexpressing Ci-Dll-B. Embryos were electroporated with DBME to misexpress CiDll-B and mRNA was then extracted to provide a qRT-PCR template to compare
expression relative to wild type embryos electroporated with the reporter construct
DBFl. Replicates were performed for each experiment in duplicate and the results
from replicates were averaged. Error bars indicate minimum and maximum values for
each gene. Differences in expression are shown on a log 2 scale. Red indicates a >2
fold increase in expression, blue a >2 fold decrease, and gray a <2 fold increase or
decrease.
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CHAPTER FOUR: SUPPRESSION SUBTRACTIVE HYBRIDIZATION
SCREENING OF CI-DLL-B KNOCK-DOWN

Introduction
This chapter describes an attempt to identify unknown targets of Ci-Dll-B.
Though unsuccessful, I gained experience with a technique called suppression
subtractive hybridization that I might be able to use in the future.
Several putative downstream targets for Ci-Dll-B that have already been
identified by others (Imai et al., 2006; Imai et al., 2012) were analyzed in this study; in
addition, attempts were made to identify previously unknown targets. Previous studies
have focused on smaller numbers of genes or looked at Ci-Dll-B as part of larger
screens. To identify genes whose regulation is altered by the Ci-Dll-B dominant
negative construct across the whole genome without the need to first identify
candidates, this study sought to make use of the technique of suppression subtractive
hybridization (SSH) (Fig. 4.1; Fig. 4.2) (Diatchenko et al., 1996; Diatchenko et al.,
1999).
To perform SSH, mRNA is extracted first from tester experimental and control
samples as a template for cDNA. These cDNA samples are then restriction digested
with a frequent cutter such as RsaI and adaptors are ligated to the experimental sample
to form the tester cDNA population at the restriction site (Fig 4.1). The adaptors
consist of one of two double stranded oligonucleotides, resulting in two tester cDNA
populations. The control cDNA used in the hybridization is not ligated with any
adaptor and becomes the driver cDNA population without any further modification
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(Fig 4.1). Hybridization occurs in two rounds (Fig. 4.2). The first hybridization serves
to subtract out those cDNAs which are not differentially expressed between the
samples. In the first hybridization each of the two tester cDNA populations is
separately hybridized with driver cDNA in excess. Since driver cDNA will hybridize
with tester cDNA, only those cDNAs more common in the tester population will not
hybridize to the driver cDNA. Among the remaining tester cDNA the more common
sequences will hybridize with each other. This normalizes this fraction of the tester
population by reducing the initially most abundant sequences from the remaining
unhybridized sample. The second hybridization is conducted immediately after the
first. The two first hybridizations are now hybridized with each other. The remaining
unhybridized tester cDNA from these two samples can now hybridize with the tester
cDNA from the other sample. Therefore after the two hybridizations, excess driver has
bound itself, nondifferentially expressed tester cDNA has bound the driver, and excess
differentially expressed tester cDNAs have bound themselves. Only normalized
differentially expressed cDNAs should be present in the tester-tester heterohybrid
population. The ends left by the oligonucleotides are filled in and PCR is performed
using primers specific to the oligonucleotide adaptors to selectively amplify testertester heterohybrids. Any hybridized template that initially includes driver cDNA will
lack a primer site at least one end. Tester-tester homohybrid template will selfhybridize during PCR due to the presence of self-annealing sequences in the
oligonucleotide adaptors. Only tester-tester heterohybrid template with two different
adaptors has primer sites on both ends and is incapable of annealing itself. The
resulting PCR product should be enriched for differentially expressed cDNA
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sequences with nondifferentially expressed sequences subtracted out. It can then be
cloned to form a cDNA library for further screening.
Initial screening of colonies from the cDNA library is typically performed
using probes derived from the same cDNA samples hybridized. The templates for
these probes are the same subtracted library that is cloned, as well as the initial tester
and driver cDNA samples as well as a reverse subtraction with the experimental
sample switched into the driver role and the control sample into the tester role. The
strongest candidates are those that hybridize to the library probe but not to the reverse
subtracted or control cDNA probes. Those colonies that do not bind the experimental
cDNA probe are still strong candidates as the SSH method is expected to enrich
differentially expressed cDNAs that are not abundant. Colonies that show more
intense hybridization to the library probe than to control probes are less likely
candidates. Colonies that hybridize to all probes or to no probes can be excluded.
Colonies that do not hybridize are potentially cDNAs that are not differentially
expressed, but are of low abundance, hindering their subtraction during hybridization.

92

Materials and Methods
Whole RNA was extracted from embryos at early tailbud stage (~9hr at 18oC)
using Nucleospin RNA XS (Macherey-Nagel, Dueren, Germany) according to the
supplier’s recommendations. First strand cDNA synthesis was performed using
Superscript III (Life Technologies, Carlsbad, CA) according to the supplier’s
recommendations using 100uM poly-T primer. The reaction was purified using
Microcon Centrifugal Filter Devices (Millipore, Billerica, MA) or a Minelute Reaction
Cleanup Kit (Qiagen, Hilden, Germany) according to the suppliers’ recommendations
and poly-G-tailed for second strand synthesis using terminal transferase (New England
Biolabs, Ipswich, MA). Reaction was purified using Microcon Centifugal Filter
Devices (Millipore, Billerica, MA) according to the supplier’s recommendations.
RACE was performed using the Advantage 2 Polymerase Mix (Clontech, Mountain
View, CA) and poly-T and poly-C primers for 35 cycles of 15 sec at 95oC, 30 sec at
65oC, and 6 min at 68oC. Reactions were purified by phenol/chloroform extraction.
cDNA was digested with RsaI (New England Biolabs, Ipswich, MA) and purified with
Minelute Reaction Cleanup Kit (Qiagen, Hilden, Germany) according to the supplier’s
recommendations to produce driver DNA. Adaptor strands were formed by annealing
the two oligonucleotide strands of the adaptors by mixing an equimolar solution and
heating to 95oC for 5 min, then slowly cooling to room temperature. Tester DNA was
then prepared by ligating driver DNA with either adaptor using T4 DNA ligase (New
England Biolabs, Ipswich, MA). Excess driver DNA was hybridized with one of the
two above testers for 90 sec at 98oC and 8 hours at 68oC in 50mM HEPES (pH
8.3)/0.5M NaCl/0.02mM EDTA (pH 8.0)/10% w/v PEG 8000. Hybridizations with
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the same driver were then secondarily hybridized with each other as well as additional
excess driver DNA overnight at 68oC in 50mM HEPES (pH 8.3)/0.5M NaCl/0.02mM
EDTA (pH 8.0)/10% w/v PEG 8000. Hybridizations were then dissolved 1:20 in
20mM HEPES (pH 6.6)/20mM NaCl/0.2mM EDTA (pH 8.0) and incubated 7 min at
68oC. For control purpose a reverse hybridization swapping control and experimental
DNA as tester and driver was also performed. Hybridizations were PCR amplified
using Advantage 2 Polymerase Mix (Clontech, Mountain View, CA) for initially 5
min at 75oC, followed by 12 cycles of 30 sec at 94oC, 30 sec at 66oC, and 90 sec at
72oC. Reactions were diluted 1:10 and amplified 24 more cycles of 30 sec at 94oC, 30
sec at 68oC, and 90 sec at 72oC using Advantage 2 Polymerase Mix (Clontech,
Mountain View, CA). Probes were synthesized by Klenow polymerase (New England
Biolabs, Ipswich, MA) using digoxygenin-dUTP (Roche, Indianapolis, IN) according
to the manufacturer’s instructions using hybridized library, reversed hybridized library
and driver DNA as templates and primed by random hexamers. The amplified library
was purified using Minelute Reaction Cleanup Kit (Qiagen, Hilden, Germany) and
cloned into pGEM-T vector (Promega, Fitchburg, WI). The cloned library was
transformed into NovaBlue Singles Competent Cells (Millipore, Billerica, MA) on
LB/ampicillin/X-gal/IPTG plates. 87 colonies passing initial color screening were
grown 3 hours at 37oC with shaking and spotted onto nylon membranes on
LB/ampicillin plates and grown overnight at 37oC. Membranes were then removed
and blotted with 0.5M NaOH/1.5M NaCl, followed by blotting with 0.5M Tris-HCl
(pH 7.4)/1.5M NaCl. Membranes were dried 30 min at room temperature and
incubated at 80oC for 120 min Membranes were washed with 6X SSPE and incubated
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with hybridization buffer for 15 min at 68oC with rocking. (Hybridization buffer: 5X
SSPE/5X Denhardt’s solution/1% (w/v) SDS/100 µg/ml sonicated herring sperm
DNA). Probes were denatured by heating in hybridization buffer and added to the
specimens and allowed to hybridize overnight at 68oC with rocking. The following
washes were performed at room temperature with rocking for 5 min each: twice with
2X SSPE/0.1% SDS; and twice with 0.2X SSPE/0.1% SDS. Membranes were then
washed twice in 0.2X SSPE/0.1% SDS for 15 min at 42oC with rocking. Membranes
were then washed once for 2 min in AP wash buffer (0.1 M Maleic acid/0.15 M NaCl/
0.3% (v/v) Tween 20) with rocking and then blocked for 30 min with rocking in 1%
Carnation instant milk in 1X maleic acid buffer (0.1 M Maleic acid/0.15 M NaCl; pH
7.5). Anti-digoxigenin antibody conjugated to alkaline phosphatase (Roche) diluted in
the above blocking solution was added to the specimens to a final dilution of 1:5,000
and incubated at room temperature 30 min with rocking. Antibody was washed out
twice with AP wash buffer for 15 min at room temperature and equilibrated in AP
detection buffer (100mM NaCl; 50mM MgCl; 100mM Tris, pH 9.5; 0.1% Tween-20)
for 3 min at room temperature. Signal was detected by incubating with NBT and BCIP
for 24 hr. Membranes were washed three times with AP wash buffer. Intensity of spot
staining was scored. Strongly scoring candidates were amplified using colony PCR
and amplified products were sequenced. Sequencing of screened clones was
performed by the University of Rhode Island Genomic Sequencing Center using
BigDye® Terminator v3.1 chemistry (Applied Biosystems, Foster City, CA). For
primers and oligonucleotides used, see Table 4.1.
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Results
To prepare cDNA for hybridization, experimental embryos electroporated with
DBDN and control wild type embryos were reared to the early tailbud stage and total
RNA was extracted. First-strand cDNA was synthesized from this using an oligo-dT
primer. To provide a reverse primer site, first strand cDNA was poly-G tailed and the
oligo-dT primer used alongside an oligo-dC primer for cDNA enrichment. The cDNA
product was then restriction digested with RsaI. The driver cDNA samples required no
further preparation while a portion of each sample was ligated with one of two
possible adaptors to produce the tester cDNA. To produce the cDNA library to be
cloned, cDNA from the experimental embryos was used as the tester and cDNA from
the wild type embryos as the driver. As a control a reverse subtractive hybridization
was also performed switching the roles of experimental and wild-type cDNA as the
tester and the driver.
After hybridization the enriched subtracted cDNA was cloned to form the
subtracted library. Transformation of the cloned library yielded 724 colonies, of which
125 passed blue/white screening. Additional transformations yielded similar total
colonies and ratios. Initial sequencing of selected colonies showed successful isolation
of suppression subtractive hybridization library sequences, but these sequences
consisted of non-cDNA contamination and non-differentially expressed genes.
A larger number of colonies were then screened by colony hybridization of
transformants and hybridization with digoxygenin-labeled probes produced from the
subtracted library, the control reverse subtracted library, or either of the two cDNA
populations used to make the library. Colonies that showed hybridization to the library
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probe, but not to the reverse library or control driver probes were classified as strong
candidates for differential expression. Clones that bound the subtracted library probe
but not the reverse subtracted library probe or that showed stronger hybridization to
the subtracted library probe than any other probes were classified as weak candidates
which could be differentially expressed, but might have only been enriched in the
library due to artifacts of the SSH method. All other probes were classified as noncandidates. Based on these criteria, out of 87 additional transformants screened eight
were strong candidates for closer analysis (Table 4.2). Further sequencing of six of
these clones and identification using NCBI-BLAST (Altschul et al., 1990)
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) failed to identify likely targets for Ci-Dll-B
differential gene regulation (Table 4.3). Two colonies were identified as incompletely
suppressed Ciona intestinalis housekeeping genes, three were identified as non-C.
intestinalis cDNA contaminants, and one could not be identified.
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Discussion
The disruption of normal cell organization by alteration in normal Ci-Dll-B
expression suggests that this gene has a role in cell adhesion mediated by targets not
yet identified. Unfortunately, efforts to identify such targets using SSH were
unsuccessful. Screening the subtracted library failed to identify any differentially
expressed candidates due to a high degree of background contamination and
incomplete suppression of non-differentially expressed genes. Many contaminant
sequences were identified as being of human origin, suggesting contamination within
the lab setting. Amplification of non-differential background sequences is a known
issue for suppression subtractive hybridization (Rebrikov et al., 2000). Amplification
of housekeeping genes as seen here frequently occurs even in more successful
screenings. This is due to the failure to completely suppress these genes as a result of
the high levels at which their transcripts are present. Moreover it is less effective at
detecting genes as the difference in expression is reduced (Ji et al., 2002). Since
alterations in cell adhesion were confined only to tissues in which Ci-Dll-B was
expressed but template RNA was extracted from whole embryos, this could represent
a low level of differential gene expression, reducing the ability to detect such genes
using SSH.
The failure of SSH to recover potential differentially regulated targets could
require the use of an alternate method. Several alternatives could be employed instead.
Microarray technology (Ali and Crawford, 2002) has previously been applied to detect
differential gene expression in C. intestinalis (Ishibashi et al., 2003; Azumi et al.,
2003). While arrays are available for use in C. intestinalis, they would have to be

98

obtained from another laboratory, and reading the arrays would require equipment not
available at the University of Rhode Island. Alternatively, recent advances in DNA
sequencing technology could allow for the sequencing of cDNA extracted from
dominant negative and wild type embryos using RNA-seq (Wilhelm and Landry,
2009; Costa et al., 2010). While an increasingly common and effective method of
obtaining differential expression data, there would be several issues to consider. Only
small amounts of total RNA could be obtained from the embryos available. This
amount of total RNA was insufficient for purifying poly-A plus RNA. The available
cDNA was amplified using rapid amplification of cDNA ends; however, this step was
one potentially prone to contamination. Since RNA-seq functions most effectively
with an mRNA template, this possible source for contamination would remain.
Finally, the sequencing reads produced by RNA-seq are short, ~30-40 base pairs, and
would require the use of appropriate computational analysis to assemble the recovered
cDNA sequences and determine which ones are differentially expressed (Pepke et al.,
2009; Garber et al., 2011). As an alternative to this, chromatin immunoprecipitation
sequencing (ChIP-seq) could be employed (Park, 2009). ChIP-seq functions by crosslinking the target protein to genomic DNA in experimental organisms, then lysing the
cells and recovering the target protein through immunohistochemistry. The linked
DNA can then be unlinked and sequenced. This technique would have the advantage
of recovering sequences from genes known to be bound by Ci-Dll-B and would not
require use of multiple treatments. Challenges would remain; mainly the lack of a
suitable antibody and the need for appropriate analytical tools to analyze the data
obtained (Pepke et al., 2009).
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While differentially expressed genes detected in these types of screenings
would be candidates for direct regulatory targets of Ci-Dll-B, further confirmation
would be required. WMISH would initially be performed to determine if the
expression pattern of the gene includes the epidermis as would be expected for a CiDll-B target. Some of this data may already be available (Satou et al., 2005). The
sequences of putative regulatory regions of these genes could then be checked for the
presence of suitable binding sites for Ci-Dll-B, identified by the consensus sequence
VTAATTRS (Feledy et al., 1999b). If found, they could be cloned and site mutations
introduced into the cloned sequences at the presumptive locations to determine if they
can still drive expression of a reporter that matches the normal expression pattern of
the gene. DNase footprinting could be used to confirm the ability of Ci-Dll-B to bind
the regulatory region of the target gene (Galas and Schmitz, 1978), but would have the
disadvantage of only demonstrating this in vitro.
Most putative targets of Ci-Dll-B already identified are transcription factors
indicating that Ci-Dll-B is not located at the end of the gene regulatory network
responsible for cell differentiation and structure. However, the ability of Dll homologs
to bind the sequence of the profilaggrin gene which codes for the precursor of the
differentiated epidermal protein filaggrin has been demonstrated in mice (Morasso et
al., 1996), raising the possibility that Ci-Dll-B could directly regulate some structural
genes. For these reasons transcription factors identified by this type of an assay could
be expected to be more likely targets. However, while structural proteins identified
could instead be targets of the network downstream from Ci-Dll-B, the possibility of
direct regulation of structural genes by Ci-Dll-B should not be excluded.
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Oligonucleotide
Poly-T Primer
Poly-C Primer
Adaptor 1 Forward
Adaptor 1 Reverse
Adaptor 2 Forward
Adaptor 2 Reverse
Primary Amplification
Primer
Secondary Amplification
Forward Primer
Secondary Amplification
Reverse Primer

Sequence
5'-TTTTGTACAAGCTTTTTTTTTTTTTTTTTTTTTTTT
TTTTTTTNN
5’-ACTTGTACTCCCCCCCCCCCCC
5'-CTAATACGACTCACTATAGGGCTCGAGCGGCCGCCC
GGGCAGGT
5’-ACCTGCCCGG
5'-CTAATACGACTCACTATAGGGCAGCGTGGTCGCGGC
CGAGGT
5’- ACCTCGGCCG
5'-CTAATACGACTCACTATAGGGC
5'-TCGAGCGGCCGCCCGGGCAGGT
5'-AGCGTGGTCGCGGCCGAGGT

Table 4.1. Primers and oligonucleotides used for suppression subtractive
hybridization.
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Clone Sub. Lib. Rev. Sub. Lib. Exp. Driv. Ctrl. Driv. Candidate
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48

**
**
*
*
**
*
*
**
**
**
**
**
*
**
**
**
**
**
**
*
*
**
**
**
**
**
*
**
*
**
**
**
*
**
*
**
**
**
**
**
*

*
*
*
*
*
*
*
*
*
*
*
*
*
*
**
**
*
**
*
**
*
*
*
*
*
*
**
**
*
*
**
**
*

*
*
*
*
*
*
**
*
*
*
*
*
*
*
**
**
*
*
**
*
*
**
*
*
*
*
*
**
**
**
**
**
**
*
-

*
*
*
*
**
*
*
*
*
**
**
**
*
*
*
*
*
*
**
**
*
*
**
*
*
*
**
**
*
*
*
*

No
No
No
Weak
No
Weak
No
No
Strong
Weak
Weak
Weak
Weak
No
No
Weak
Weak
Weak
No
No
Strong
No
Weak
No
No
No
Weak
No
No
Weak
No
No
Weak
No
No
No
Weak
Weak
No
No
Weak
No
No
No
No
No
No
No

Clone

Sub. Lib. Rev. Sub. Lib. Exp. Driv. Ctrl. Driv. Candidate

49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
Neg. Ctrl. 1
Neg. Ctrl. 2
Neg. Ctrl. 3
Neg. Ctrl. 4
Neg. Ctrl. 5
Neg. Ctrl. 6
Neg. Ctrl. 7
Neg. Ctrl. 8
Neg. Ctrl. 9

**
*
**
**
**
**
**
**
**
*
**
*
*
*
**
**
**
**
**
**
**
**
**
**
**
*
**
**
**
**
*
*
*
*
*
*
**
*
**
*
*
*
**

**
*
**
*
**
**
*
*
*
**
**
**
**
*
**
*
**
**
**
**
*
*
*
**
*
*

*
*
**
**
**
**
**
**
**
*
*
*
*
*
**
**
**
**
**
**
*
*
**
**
**
**
*
*
*
*
*
*
*
*
*
*
-

*
**
*
**
*
*
*
*
*
*
*
**
**
**
**
**
*
*
*
*
*
*
*
*
*
*
*
*
*

No
No
Weak
No
Weak
No
No
No
No
No
No
Strong
Weak
Weak
Weak
Strong
No
No
No
No
No
No
No
No
No
Weak
Weak
Weak
No
No
Weak
No
No
No
Strong
Strong
Strong
Strong
Weak
No
No
Strong
Weak
No
Strong
Strong
Strong
No

Table 4.2. Scoring of suppression subtractive hybridization colony screening.
Colonies were spotted on nylon membranes, grown overnight, lysed and cross-linked,
and then probed with digoxygenin labeled DNA probes synthesized from subtracted
library, reverse subtracted library, experimental driver, or control driver templates.
Probes were bound with alkaline phosphatase labeled antibody, visualized and scored
as showing strong hybridization (**), weak hybridization (*), or no hybridization (-).
The scoring pattern was used to classify clones as potential candidates for differential
expression. Clones that bound the subtracted library probe and neither control
template probe were classified as strong candidates (shaded). Clones that bound the
subtracted library probe but not the reverse subtracted library probe or that showed
stronger hybridization to the subtracted library probe than any other probes were
classified as weak candidates. All other probes were classified as non-candidates. Nine
colonies that did not pass initial blue-white colony screening were included as
negative controls.
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Clone Sequence
60 AGCGTGGTCGCGGCCGAGGTACAGGTGAATTAATATTACTTCAGCATTAC

Base Pairs Identification

Classification

E Value

496 Unknown

Unknown

N/A

139 Homo sapiens Contactin 4

Contaminant DNA

6E-54

330 Ci-MAP Kinase 8 interacting protein 1

Ci Housekeeping Gene 3E-04

229 16c02 Ci Genomic Sequence

Contaminant DNA

430 Ci-SMC1A

Ci Housekeeping Gene 6E-64

107 Homo sapiens Genomic DNA

Contaminant DNA

GTAATATCATCGAAGGCCGTTTCGGATTCACCAGAATTTTGGCAATAATT
TAAACTTGTAAAACTCGCCTGCAAACTCAAATTCGAGAAAAATAGACTAA
GCTCAGCTCAGCTCTAAAAAATTAAAATAATTATAGCTATATTTTTACGT
TTTCTTGCAGGTCTAAAACGTTCGGATTTTTGGTTATGCTGGTCCTACTT
ATCGGAAGCACTTTAATAACAGGCGTTCTGTCAAAGGAAACAAACTTGCA
ACCGACACCAATTGGCGTCAACCTATACATGTCAATGTATGTTGTGATAC
TTATAACTTGGATTTACGGACATGAGTTTGATCTGTATATACTTTGATAC
TATTAGCTATATAGATTATACTGTAATCGGCCTTTTTATTTGGCGCCAAT
ACTTTCAATAAGGGGCAAACAAAGTACCTGCCCGGGCGGCCGCTCG

64 AGCGTGGTCGCGGCCGAGGTACCCTTATCTAGAAGTTATAAATAGGTTTC
AAAATAGTCAATTTGGTCAACTCCACCATTTAAGGCAGGCAGAAACAAAA
ACACCTGAGAAATGAGTGACTTATTGCGGGGGGGGGGGG

83 AGCGTGGTCGCGGCCGAGGTACCGCGACATAGAGATGAAATACAACTAGA
GGTAAAGTGTGTTTATGTTTATTTATATTATATATACTGTTGCTAAGGCG
TTTTATAATGTTTACAACAAAATAGATCTTTTTCAAATTTTATTTAAACT
GATGACGTAAATATCTTTATTGTTGTAGCTACTAGACGTAGTGTAATGTA
ATGTAAAAGTGTTAATATATAAAAGATATCTTTTTACCACAGGGGGGGGG
GGGGGAGTACCGGCCGGGGGGGCCCCCCAAAATCCCTAGGGAATTCCCGG
CCCCCTGCGGGTCAACCATTGGGGAAACCC

84 TCGAGCGGCCGCCCGGGCAGGTACTGTTGCGTTACATTCCCTGATGAAGT
CTCGCCGTATGGCAGATGAAACGTTGGAAATTATTACGTTTTTTATACCG
GATGAGCCGCTAAAATATTATGATTTCTCGTTTTCGATGTTCTTTAGTCC

1E-22

TTGTCCACAAACAGTTCGGCGTTGCTAACAGTTGGCTGGGTTTTATATTG
TTTCGCAGTACCTCGGCCGCGACCACGCT

85 AGCGTGGTCGCGGCCGAGGTACGATGACTGTAAACACAATATTATCTAAT
GTGAATACCCAATACAGGGGAGGCAGTGCGCACATTCCTGTAAAACAAAT
CTAATCTATTGTTTGTAATGTTTATTGAATAGCCTAATACAGTGTAGAGA
ATTCCAGGGTAGGCCTGTCAATCCTGCCACCCCAGGGTTGGTGCCTACGT
TAATACATTTATGTAAAAAATGTTATTTTTCTTCTCAGATTAGATGCTGA
GCGTCGTAAAAAGAGCGAGTTATGGTCCCAACAGAAACAGAAGAAAAAGG
AGCTGGAAGAATCAAAGTCCCGAGTTGATAAGTTGAAAGATTACATTGAA
ACAAGTCACACTACACTACAGGAACATAAGAAACTGAAGGTGGATTTAGA
AAAGCAGGTACCTGCCCGGGCGGCCGCTCG

86 AGCGTGGTCGCGGCCGAGGTACCTCTCCCCTGTGGGATTGTTCACAGTAT
CCAAAAGGGAAGAGGATGATGTTACTCCCAATATCACAGGGGGTGTACCT

5E-33

GCCCGGG

Table 4.3. Sequence analysis of selected suppression subtractive hybridization
library clones. The inserts of six colonies classified as strong candidates by the
suppression subtractive hybridization colony screening were sequenced using standard
vector primers. The inserts were identified and those that were identifiable classified
as either incompletely suppressed C. intestinalis housekeeping genes or non-C.
intestinalis cDNA contaminants.
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Figure 4.1. cDNA preparation method for SSH. Green represents the tester cDNA
(DBDN), red represents the driver cDNA (wild type), yellow represents primers for
cDNA synthesis, and blue represents the adaptors annealed to the digested tester
cDNA. Driver cDNA is ready for hybridization after RsaI digestion while tester cDNA
is ready after adaptor ligation.
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Figure 4.2. Scheme of the SSH method. Green represents the RsaI digested tester
cDNA (DBDN), red represents the RsaI digested driver cDNA (wild type), and blue
represents the adaptors annealed to the digested tester cDNA. Note that after the
second hybridization, the recessed 3’ ends produced by the adaptors are filled in
during the initial cycle of PCR amplification and that molecules having adaptor 2 are
also present but are not shown.
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